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manufacturing of biodegradable implants from its subsidiary in Finland to two facilities in 
the United States of America. This decision raised some business challenges. How to 
transfer manufacturing of biomaterial implant products with minimal impact to stakehold-
ers, and how to ensure continuous high quality, safety and production yield of biomaterial 
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create a best practices process for the transfer, uncover risks and working solutions for the 
manufacturing steps of a biomaterial implant product. The thesis focuses on transfer of 
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1 Introduction 
 
US based company has decided to consolidate production from its Finland operations 
to its two sites U.S. by 2014. This is consistent with company’s strategy to improve 
Manufacturing & Operational Efficiencies (US Vice President of Operations 2012).  
Products manufactured in company’s Finland subsidiary, after this also referred as Fin-
land Operations (OPF), are unique and they have only been manufactured in Finland. 
OPF is a pioneer in the biomaterials field having over two decades of experience man-
ufacturing biodegradable products and is inventor of proprietary technologies. Employ-
ees are skilled, flexible and able to deal with the various situations and issues. Suc-
cessful research on new biocomposite materials have been carried out for years and 
co-operation with the material suppliers is tight. Proven expertise in the processing 
techniques used for composites and use of modern materials. Company has consist-
ently introduced new products, product lines and materials to the market. Quality man-
agement system is of a high standard also from the authorities' point of view with prac-
tically no auditing deviations. Reliability of customer deliveries and high customer satis-
faction based on low number of complaints shows affective and flexible production pro-
cesses, which also allows small production batches. (Strengths of Finland Operations 
2012)  
A lot of the points mentioned above are not at the same level in the receiving manufac-
turing facilities in the US. There is a danger that a lot of the knowledge and efficiencies 
will be lost unless the transfer of the manufacturing is done properly. In worst case 
scenario customer deliveries could be impacted and quality issues could even lead to 
factory shutdowns or costly product recalls (FDA 2014). 
 
In this case the recipient organizations have little or no experience in working with bio-
degradable materials used in OPF, so transferring that knowledge is important. OPF 
personnel has a lot of tacit or hidden knowledge developed during the decades of 
manufacturing biomaterial implants. Finding ways to transfer this knowledge is one of 
the focus points of the research. Imagine changing a tire in a car. The work instruction 
guides to remove four nuts and then to remove the tire. When trying to remove the third 
nut, it is rusted and stuck. Applying too much force can break the retaining bolt and 
then the car cannot be used until retaining bolt is fixed. Work instruction does not pro-
vide answers to all of these of issues. The experienced tire changer would just apply 
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chemical “rust off” or equivalent, then wait for a few moments and remove the third bolt 
continuing the process. Polanyi (1966) noted, ‘‘we can know more than we can tell’’. 
The discrimination between tacit and explicit knowledge. 
 
1.1 Case Company Background 
 
US Based company is a major medical products manufacturer specializing in surgical 
instruments and other medical devices. Company manufactures medical device prod-
ucts in nine different areas Arthroscopy being one of the areas. Company growth strat-
egy has been based on acquisitions especially in 1990s. Little consolidation has been 
done until recently and company still owns many independent subsidiaries. Company 
has started implementing extensive consolidation strategy (Company website 2013). 
 
Finland subsidiary (OPF) is independent subsidiary of US Based Company and works 
in close co-operation with other US subsidiary to provide arthroscopic instrumentation, 
implants, fixation and tissue repair systems for orthopedic purposes. US subsidiary is 
responsible for marketing, sales and distribution of these products. US subsidiary has 
extensive strategic control over the Finland subsidiary as the managing director of OPF 
reports to US subsidiary Vice president of Operations. OPF exports and sells all the 
products to US subsidiary using transfer pricing. (Finland subsidiary e-portfolio presen-
tation 2012).  
 
Approximately 60% of the Company’s revenues are derived from products designed for 
the orthopedic surgery markets of arthroscopy and powered surgical instruments. Capi-
tal equipment such as powered drills and surgical hand-pieces are marketed to support 
the sale of disposable products. US based company distributes its products globally 
through its own U.S. sales network, international direct marketing in nine countries, and 
specialty distributors in other countries. (Company Website 2013) 
Legislation in all the areas for medical device products is strict but stable and major 
sudden changes are very rare. Recalls do happen sometime and, depending on the 
issue, can be costly. (FDA 2013, medicaldevicerecall.com/ 2013) 
 
US based company customers are Surgeons, Nursing Directors, GPO’s (Group Pur-
chasing Organization), IDN’s (Integrated Delivery Network) and Governmental Institu-
tions. Surgeons are the ones that have great influence on decision what products they 
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use. End users (Patients) are not usually aware what options they have, so many times 
it’s up to the surgeon or doctor to choose the products used. Medical insurance covers 
most of the incidents, so end users tend to want the best available solution that is rec-
ommended by their doctor. Quality products, good relations and proven track record 
with the customer is paramount for success. Customer input is also very important in 
developing future products that suite the customer needs. (WHO, US based company 
investor presentation 2012). 
 
1.1.1 Current state supply chain management 
 
One of the US based company’s key performance indicators (KPI) and competitive 
strategies are the next day delivery of disposable products (implants etc.) and 10 day 
delivery of capital products (power drills etc.) Customers are served first in first served 
bases (Vice President of Operations 2013). Demand inputs come mostly from market-
ing department and historical sales data. Due to next day delivery strategy US based 
company has to keep enough products in stock to fulfil this promise and that tends to 
drive inventory costs up. US based company supply chain management (SCM) is tradi-
tional and vertically integrated, meaning that they produce many of the components in-
house instead of outsourcing. Raw materials and other supplies are sourced close to 
the main manufacturing facilities which are located in North America. Finland manufac-
turing facility is the only one located in Europe. Distribution centers are located world-
wide in North America, Europe, Asia and Australia. The largest distribution center is 
located in US (Company website 2013). 
 
 
Figure 1. US based company Supply Chain management Structure 
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Finland subsidiary sources materials and machinery from European market and deliv-
ers final products to US based company’s distribution centers and semi-finished prod-
ucts to US Manufacturing facilities for further processing. 
 
 
Figure 2. Finland subsidiary Supply Chain management Structure 
 
  
1.2 Business Challenge, Objective and Intended outcome 
 
US based company’s transfer decision has raised some business challenges that were 
identified by reviewing the transfer announcement presented by Director of Operations 
and following discussions with Operations management. 
 
How to transfer manufacturing of a biomaterial implant products with minimal impact to 
stakeholders? 
How to make sure continuous high quality, safety and production yield of biomaterial 
implant products when manufacturing is done in the United States? 
 
Thesis goal, agreed with Operations management, is to create a best practices process 
for the transfer, make manufacturing process step risk analysis and create solutions 
toolkit to challenges that will most likely be encountered during the transfer and in con-
tinuous manufacturing of a biomaterial implant product in various manufacturing steps. 
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OPF products are similar between each other, so results should be applicable to other 
OPF implant products as well. Results would aid with the seamless transfer of manu-
facturing from Finland to U.S. and solving issues that might rise at a later time in manu-
facturing processes at receiving site.  
 
1.3 Scope and Limitations 
 
1.3.1 Scope 
 
Research focuses on the transfer and manufacturing steps at the shop floor on one 
specific product family. Finland subsidiary has 400 different products in their line-up 
and seven major product families. Main manufacturing methods are extrusion, self-
reinforcement, machining, thermoforming and injection moulding.  Scope of the thesis 
is limited to transfer of one biomaterial implant product, after this called ImplantX, which 
is available in various lengths. This product has been chosen because it is manufac-
tured in machined and injection moulding methods, covering two main manufacturing 
methods used at OPF. Assumption is that the research will capture common issues 
and challenges in both manufacturing methods. ImplantX is also part of the successful 
Sports medicine product line, which accounts for over 30% of US based company rev-
enue. Transfer of Research & Development functions are out of scope for the thesis. 
  
The ImplantX line introduces the latest advancements in biocomposite material tech-
nology. Material is a result of extensive research at the Finland subsidiary facility. Ma-
terial utilizes micro filtration process that yields β –TCP (Beta-tricalsiumphosphate) 
particles in their smallest form, known as microTCP with average particle size of 5-30 
µm. MicroTCP particles are uniformly embedded throughout 96L/4D PLA Bioabsorba-
ble polymer, delivering a stronger biocomposite material. This technology enables reli-
able fixation during the healing period while promoting bone in-growth to aid in the res-
toration of patients’ natural anatomy both biologically and mechanically. (US subsidiary 
Arthroscopy catalogue 2012) 
 
ImplantX is for ligament fixation in the knee area. Larger implants are designed for fixa-
tion of ligamentum cruciatum anterius and ligamentum cruciforme atlantis. Smaller im-
plants are designed for fixation of other ligaments in the knee area. Product family con-
Master’s Thesis 
6 (64) 
 
 
sists of 35 sizes developed at OPF and the instrumentation for the applying of the im-
plant has been developed by US subsidiary.  
 
Scope of the Risk analysis and Solution toolkit are limited to manufacturing process 
steps of ImplantX product.  
 
 
Figure 3. Example of implant product family (OPF e-portfolio 2012) 
 
1.3.2 Limitations 
 
Research has a number of limitations. Research is conducted inside one company and 
focuses only on one product family. However skills acquired from manufacturing of this 
product family could, in most manufacturing steps, be applied for other OPF products 
according to the results from the survey and interviews. Some manufacturing steps had 
only few responses in the survey, which causes individual answers to gain more prec-
edence. End customer feedback from the case transfer is not available at the moment 
of writing this thesis, so the case transfer success cannot be definitively evaluated. 
Conclusive evaluation of the transfer could be done after few years, when all the OPF 
manufactured safety stock is used and customer feedback from the products manufac-
tured in receiving location is available. Best Practices process built is mainly based on 
interviews, experience and literature, but has not been tested in practice with empirical 
results.  
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2 Methods and Material 
 
2.1 Research Design 
 
The research methodology is empirical and qualitative based on relevant literature, 
company documentation, a survey conducted in the company and 11 expert interviews 
including project management and uncovered manufacturing process step experts. 
Author was part of the transfer, responsible for the information systems and data trans-
fer with a good access for transfer follow-up. 
 
The research design followed the pattern of first getting familiar with relevant literature 
and company documentation, then internal survey and interviews were conducted. Re-
sults from survey and interviews were used in the case review and analysis, which lead 
to a proposal. Proposal was then subjected to review by OPF and after feedback con-
clusions were formed. 
 
Company Documentation and 
Relevant Literature review
· Selecting product
· SOP,WI,MI etc.
· Journals
· Academic literature
· Practicioners literature
Internal Survey
· Risks/Issues
· Solutions
· Knowledge requirements
· Correlation
· Uncover experts
Interviews
· Theme interviews
· Five transfer project 
focused interviews
· Six manufacturing process 
focused interviews
Case Review and Data 
Analysis
· Product details
· Process details
· Successes
· Challenges
· Risks
· Recommendations
· Training times
Building a Proposal
· Best Practices process
· Risk Analysis
· Solution Toolkit
Customer Review
· Feedback on the proposal
· Change requests
Conclusion
· Final version of the 
proposal
· Next steps
· Evaluation 
Identifying Business 
Challenge and setting thesis 
objective
· Transfer announcement 
review
· Discussions with 
Operations 
management
 
Figure 4. Research design 
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2.2 Data Collection and Data Analysis Methods 
 
ImplantX manufacturing information was gathered from company’s internal documenta-
tion including standard operating procedures, work and equipment instructions. Survey 
questions were focused on the manufacturing steps of ImplantX product. Purpose of 
the survey was to uncover knowledge experts in the organization and gather infor-
mation from personnel in order to achieve research goals. Survey was structured by 
each manufacturing step and answering a step was optional. It consisted of open text 
fields, choices and lists. Choice questions were limited to four possible answers. Since 
the survey was targeted for Finnish personnel, the questions were in Finnish language 
in order to avoid misunderstandings.  Survey was built on SharePoint server 2010 plat-
form and users answering the survey used their own Microsoft active directory user 
account and computers provided by the company. 47% of the personnel responded to 
the survey. 
Survey uncovered the experts of each particular manufacturing step and many agreed 
to be interviewed for the manufacturing process step of their expertise. The transfer 
project leadership, project managers and managing director were also interviewed, 
their interview questions were mostly focused on overall transfer for case review. Total 
of 11 recorded interviews were conducted lasting from 17 to 45 min. Interviews includ-
ed open-ended questions concerning the research topics. Additional focusing ques-
tions were asked by the author during interviews. Author also engaged in several unre-
corded conversations about the transfer with the personnel that helped to highlight fo-
cus points.  
 
3 Case analysis of the manufacturing transfer 
 
In spring 2012 US Based Company consistent with their strategy to improve Manufac-
turing & Operational Efficiencies reviewed Finland operations and set certain targets for 
improvement. In the end they came to a conclusion that targets could only be met by 
transferring the Finland operations to United States. US Based company decided to 
consolidate Finland manufacturing operations to two manufacturing facilities in North 
America by 2014. Receiving organizations are referred as Rsite1 and Rsite2.   
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3.1 Transfer in general 
 
Finnish labor laws are very different from the US labor laws according to overall trans-
fer project manager. US based company has done manufacturing transfers multiple 
times within the North America region, but not international transfers from Europe. 
There were additional legal issues that management had to take into consideration, 
Finnish joint negotiation law for example. 
According to the project management interviews, once the transfer decision had been 
made, the project for transfer was not very different from a normal big international pro-
ject except that the end result was a shutdown of Finland operations. Project schedule 
was created and responsible project manager for the project was chosen. In this case 
the project manager came from US subsidiary (Rsite1) and she was overall responsible 
of the transfer project. Finland Operations (OPF) requested that there would be a local 
project manager in Finland site, which was agreed, and local project manager was ap-
pointed in OPF. Overall Project manager could not choose the transfer team members 
herself, they were chosen by respective directors from receiving (Rsite1 and Rsite2) 
and sending organizations (OPF). There was no transfer process template or best 
practices process available, but the experience of the project managers that have done 
transfers in US were used in the pre-transfer planning. There was extensive experience 
of transferring documentation and other practical matters. Original purpose was to copy 
the processes from previous completed transfers and apply them. However this was 
international transfer from Finland to US, products and manufacturing methods trans-
ferred were very different from the previous completed transfers. This resulted that only 
basic outline of the transfer process from previous transfers was used and previous 
experience indicated that estimated transfer time would be about 18 months. Finland 
personnel was offered a generous bonus system that rewarded the personnel staying 
for the duration of the transfer. About 90% of the personnel stayed to collect the bonus, 
which ensured availability of the valuable human resources. Company also offered 
other kind of support for the personnel in Finland, a job search training for example. 
 
3.2 Pre-Transfer planning 
 
First step was to determine what products are manufactured in OPF, how many cata-
logue numbers, products and product families there were. Then among those cata-
logue numbers, how many of them are in product families and how many of them are 
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components compared to final products, and what effect that has for the transfer. Re-
view of the manufacturing methods was conducted to find out whether product was 
machined or Injection moulded. Process flow chart was created for each of those fami-
lies. Machined process products were to be transferred to Rsite1 and assembled into a 
final device there. Moulded products were to be transferred to Rsite2. Some products 
didn’t necessarily fit into either facilities current capabilities and receiving site needed to 
be determined separately in those cases.   
From equipment standpoint decisions were made to either purchase new equipment to 
receiving site or to transfer the equipment from Finland. This was based on availability 
of the equipment, for example Extrudex is fairly common extruder versus the self-
reinforcing equipment which is custom made equipment, so determining if it made 
sense to purchase new equipment in the US or transfer equipment from OPF. Custom 
made equipment that could not be purchased easily were to be transferred and that 
required to build up more inventory of those products, because there is going to be 
some time period, were there is no manufacturing being done. For the machined prod-
ucts, a new machines were to be purchased in Rsite1, which would enabled Finland to 
continue manufacturing products until Rsite1 was capable manufacturing products, and 
so there was not going to be that time period where there is no manufacturing. There 
was planning from inventory standpoint of how much safety stock is needed to cover 
transfer periods. Finland needed to make more products and determining how long that 
was going to take had to be scheduled.  OPF was suddenly asked to make 10 months’ 
worth of extra inventory in particular products during pending shutdown. This was a 
challenging resource issue for local OPF management. 
There were also determining from the regulatory stand point of what regulatory impact 
transfer has. There are differences if the final product is already manufactured in re-
ceiving site in US or the final product is completed in OPF, and if transfer is considered 
a major change or not from regulatory stand point. The estimated time the regulatory 
submissions and approvals would take, also influenced decision on how much safety 
stock was needed. 
Sales Data was reviewed of whether it is related to regulatory impact as well. If there is 
longer regulatory time period like in Korea for example. How much, what percentage of 
the product is actually sold in Korea and what is the impact. Sales figures of each 
product line was reviewed, in which markets and what regulatory impacts there were. 
Then the amount of additional safety stock was calculated with estimates of other rele-
vant effects. Few product lines were considered for discontinuation like one implant 
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family, which was sold primarily in China. Product had very low profit margin and it 
would take a long time to get it resubmitted for regulatory approval. Cost Analysis and 
payback estimates were made for the products which had very low profit margin and 
the decisions to discontinue were made on selected products.  
 
3.3 Transfer overview 
 
Order of the transfer was decided according to the project plan to start from latter pro-
cess steps. First manufacturing process steps to be transferred were Injection mould-
ing, packing, machining and laboratory measurement. Extrusion and Self-
Reinforcement processes were positioned to end of the transfer schedule. Safety 
stocks for final products and components were build based on the project plan. De-
tailed project plan was available only to transfer product management. Discontinuation 
decisions were also made during the transfer, which created confusion and delays 
when building safety stocks and a wrong product was manufactured at times. 
There was a team within Rsite1 which was assigned to get manufacturing up and run-
ning of the machined implants that were assigned to Rsite1. They had to build a clean-
room, order machining equipment etc. There were people from several different de-
partments assigned to the project. Products transferred to Rsite1 were all component 
products and final product assembly was already done in Rsite1. Personnel in Rsite1 
had worked on those products before and therefore had some background in trans-
ferred products.   
Rsite2 had their own team assigned and they, like Rsite1, had to build a cleanroom 
facilities. They were not familiar with implant manufacturing, so they had to get them-
selves acclimated and learn issues of working with biomaterials and implants. They 
had to implement new processes in order to ship component level implant products to 
Rsite1 that were not in place previously. Test laboratory had to be setup in Rsite2 
among other things, so there were a lot more activities in Rsite2, if you look at the scale 
the whole project, then in Rsite1.  
Overall Project Manager had no previous contact with anybody in Rsite2 facilities and 
she was in charge of managing project also between OPF Finland and Rsite2. Learn-
ing how Rsite2 and Rsite1 organizations worked together and to get familiar with the 
team members and their skills was required. There are cultural differences between 
Rsite1 and Rsite2 even if they are located in the same country. Corporate culture in 
Rsite1 and Rsite2 is also different, which created barriers for the transfer. 
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Documentation in OPF was mostly in Finnish, so it needed to be translated into Eng-
lish. This was done by using internal and external service providers. Translations were 
added to the documents and reviewed by OPF Quality Assurance and Research and 
development Departments that understood technical issues in processes. They made 
sure the translations were correct. Documents were then scanned to digital PDF form 
and sent to corresponding locations in Rsite1 or Rsite2, where they were imported into 
quality systems. There was a lot of coordinating between three sites for making sure 
that information was provided when needed, but also trying to make sure, that infor-
mation was verified by Rsite1 Quality department, so that in the end, the correct final 
revision of the documents will be the one available. There was a tendency for one-to-
one communication, for example someone in Rsite2 was working on something and 
have been talking to somebody on one-on-one level in OPF asking them questions. 
They might send information back and forth, and manager needs to make sure that 
ultimately the final released revision of the document is the one translated and import-
ed into quality system. A majority of the release documents were also scanned and rest 
of the documents were archived with instructions from the US in the archive boxes and 
then sent to US for final archive. One of the quality requirements was that document 
content and meaning cannot change at all, so Finnish part of the document is consid-
ered valid in case there is any conflict between English and Finnish text. Also due to 
this requirement, no indexed PDF –files were used. This limits the future indexing and 
searching of the PDF documents, but is necessary because OCR (Optical Character 
Recognition) and PDF transformation tools available in OPF might change some as-
pects of the content or appearance of the document compared to original. User per-
sonal home drive files and email archives could not be sent to US due to legal issues, 
so this particular data was archived in US based company sales office located in Fin-
land. 
Rsite2 also had to have bio-absorbable implants production added to their manufactur-
ing certificates, which they did not have before and Rsite1 had to add Rsite2 as a sig-
nificant subcontractor onto their certificates. This issue came up when process to do 
regulatory submission was started and there were additional regulatory requirements 
that were not known ahead of time.  
Resources were being drained. Everybody was asked to do more work, but also main-
tain the service levels during that time period. Finland operators were training US per-
sonnel on how make products during their visits in Finland, while at the same time do-
ing overtime in order to increase safety stock levels. Finland Personnel were kept in-
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formed about transfer progress by info sessions held as often as needed, at least once 
a month. Personnel also received support and information about their options after their 
role in the transfer was over. 
Once the safety stocks were completed for a particular products, the Finland manufac-
turing equipment of those products was transferred to US facilities and process of 
ramping up manufacturing of these products in receiving site was started. Transfer 
progressed in phases by each product family. Process validations needed to be done 
in receiving site before any actual manufacturing can start. Receiving sites had trouble 
successfully completing process validations especially with older products. A number of 
expert visit from OPF to receiving site was done and OPF personnel helped with these 
validations. 
 
3.4 Knowledge transfer 
 
There were number of people visiting the Finland operations from Rsite2 and Rsite1 
during the transfer period. They were learning the use of equipment and manufacturing 
process steps in manufacturing area. Some had extensive previous experience and 
some had very little previous experience. Most visits lasted from one week to two 
weeks. Injection moulding specialist and process engineer from Rsite2 stayed longer, a 
few months in total. They were learning injection moulding, extrusion, thermoforming 
and self-reinforcement. They also documented processes by taking video and pictures, 
and reading the translated work and equipment instructions. Finland personnel also 
visited Rsite2 and Rsite1 and helped them ramp up their manufacturing. These trips in 
general lasted from one week to two weeks. None of the Finland manufacturing experts 
relocated to US. One Research Development Manager and Finland transfer Project 
manager relocated to Rsite1 and Rsite2. Rsite1 tried to recruit two additional persons, 
but there efforts were unsuccessful. 
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3.5 Cultural challenges 
 
Cultural differences between US and Finland affect the transfer and the training. Lan-
guage was the biggest obstacle at the beginning, especially with technical terms. Op-
erators in Finland were not used to speak English and at first were a bit timid with visi-
tors from United States of America. As time went on they felt more comfortable of in-
teracting and technical language terms became more familiar. Language issues 
caused training to take more time, because operators had to explain procedures many 
times and they had to make sure everything is understood correctly. Some operators 
interviewed expressed a concern that even if US visitors performed the operational 
tasks they did not really understood why the process is done this way. This could be 
interpret as a lack of absorptive capability. Language problem did not persist with the 
office personnel, however there was some miscommunication at times. An example of 
Rsite1 sending people to pack-up equipment faced a resistance, because persons in 
OPF thought Rsite1 didn’t trust them enough to do the equipment packing. The real 
reason being that Rsite1 personnel needed to see the equipment before it was disman-
tled so they have a better change to properly assemble it in the receiving site. OPF 
office personnel had worked with Rsite1 personnel before, which made communication 
easier. The abundance or lack of daylight in Finland caused various issues for some 
visitors.  Finnish personnel received positive feedback from US visitors in separating 
personal feelings from work and general professionalism throughout the transfer. Re-
ceiving sites also mentioned how very helpful Finnish personnel were compared to 
their experiences with transfers inside the US.  
Work and corporate cultures differ between OPF and US sites. Finnish tend to be more 
loyal to the employer and stay longer in service. Manufacturing workers in Finland tend 
to have more responsibility. OPF operators do machine settings, measuring and report-
ing. In US the hierarchy has more levels, operators basically just push a button and run 
the machine. Machine settings are done by technician, measuring by quality personnel 
and supervisor does reporting. Finnish operators are very straight forward in case of a 
problem, they bring it out in the open immediately and ask for help. In US they would 
probably try to solve issue by themselves and only ask for assistance when nothing 
works or even try to hide the problem exists. It seems more acceptable in Finnish cul-
ture to reveal that you do not know and need help then in US. Admitting a mistake or 
requesting additional training seems difficult for the US personnel. Mistakes are more 
like unfortunate events rather than lack of skill.  
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3.6 Implant transfer case 
 
When the transfer project first started ImplantX was being machined in Finland and 
initial plan was to transfer the machining to Rsite1 and then make the change to mould-
ing in Rsite2. That was primarily due to regulatory reasons. Each of those changes 
being considered a major change by some regulatory bodies. Decision was made to 
change the production to moulding in Finland and then move the moulding production 
from Finland to Rsite2. This eliminated the intern step of transferring machining, in 
which some of the equipment purchases planning were based on. So there were con-
stantly changes being made to the project plan. Rsite2 was getting their moulding 
equipment up and running at the same time as OPF was doing validations of a mould-
ed product. Packaging into foil pouches was added into packing process in Rsite2, 
which had never been done there before. Sterilizing with a special low dose Gamma 
cycle was added, that US based company in the US has never dealt with before, and 
the sterilization supplier, which could provide those services, was sourced in the US. 
Sterilization with low dose Gamma was something totally new to Rsite1 and Rsite2, 
neither had any previous experience in that process. Rsite2 had to do the moulding 
validations, but also sealing validations and sterilization validation. All these steps were 
considered major changes to some regulatory bodies and subject to regulatory sub-
mission.  
Injection moulding process was rigorously created and validated according to newest 
requirements in OPF Finland. Primary operator from Rsite2 had 4-5 years previous 
experience in injection moulding and he spend few months in cleanroom practicing 
biomaterial injection moulding with Finnish Injection moulding expert. Finnish Injection 
moulding expert and quality engineer also visited Rsite2 site a few times to verify the 
processes were running and validations have been completed properly. There has not 
been any major issues in injection moulding manufacturing after the transfer. Two 
years supply of raw material billets was manufactured in OPF for this process. Transfer 
of Compounding and pelleting processes needed for making raw material components 
for Injection moulding is scheduled to be completed by summer 2014. 
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3.7 Manufacturing overview of ImplantX 
 
ImplantX can be manufactured in two different ways, Machined or injection moulded. 
Originally the machined process was used, and after 2011 the injection moulding pro-
cess was implemented. Both manufacturing methods are validated and have neces-
sary regulatory approvals. Two lathes are used in machining process, the product 
manufactured in this way is slightly more costly compared to the injection moulded pro-
cess. One lathe could be enough if it had enough tool slots available. Both manufactur-
ing types presented are also widely used in other OPF implant products. OPF manu-
factures the finished product, which is then sterilized and delivered to the customer. 
The control of sales permit is the responsibility of US subsidiary Rsite1’s regulatory 
department. 
 
Manufacturing process includes many steps and these steps generally have sub-steps 
within production cell. Detailed Documentation is available for each step explaining 
how each component is manufactured, equipment is setup/used, how process is vali-
dated and quality is assured. Documents include work-, equipment- and measurement 
instructions, and validation documentation. Product specific tools and measuring 
equipment used during the each process step is listed in the documentation. This doc-
umentation was used as a source in the description of the manufacturing steps. 
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3.8 Machined Process 
 
In this process ImplantX products are created by compounding, self-reinforcement and 
machining. 
 
Ultra-high strength, self-reinforced, macroscopical biodegradable polymeric com-
posites can be manufactured by creating the polymeric microstructure, where 
oriented reinforcing elements and matrix material, which have the same chemical 
element composition, are bound together. (P. Törmälä 1992) 
 
PACKING
Printing of labels
Packing to a holder
Packing and sealing of foil pouches
Packing and sealing of Tyvek-pouches
Placing of Tyvek pouch to a gamma box
STERILIZATION
Sterilization sub-contracted
RELEASE
Lot Approval
Customer Packing
Packaging of sealed products, patient 
labels and IFUs to Hospital boxes
Gamma Packing
Gamma Packing
Closing of transporation box
COMPOUNDING
Drying of raw material
Compounding
MACHINING
FINISHING
Peeling
Cutting
Machining
Finishing
SELF-REINFORCING
Self-Reinforcing
WASHING
Ultrasonic washing
Vacuum drying
 
Figure 5. Machined ImplantX manufacturing process 
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3.8.1 Compounding 
 
In this step composite materials are manufactured from raw materials by continuously 
mixing bioactive ceramic (β –TCP) to biodegradable polymer (96L/4D PLA) using melt-
processing method twin-screw extruder. End result of the process is composite billet, 
which is a bar used in the following manufacturing steps. 
 
Compounding is done in controlled cleanroom environment. Process step includes dry-
ing of raw materials in vacuum oven and compounding them with twin-screw extruder. 
Single screw extruder cannot not be used to mix liquids and powders to polymers ho-
mogeneously, so the twin-screw extruder was developed for this purpose. Process can 
take an hour to produce a billet. 
 
In-Process quality control consists of following tests: Measurement of billet diameter, 
Measurement of TCP-content, Measurement of inherent viscosity, determination of 
monomer content and Visual inspection of the billet. 
 
 
 
Figure 6. Twin-Screw extruder cell 
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3.8.2 Self-reinforcing 
 
In this step billet from compounding step is self-reinforced using custom made equip-
ment that with heat and mechanical force slowly elongates the billet causing it to 
stretch to a predefined ratio and at the same time causing polymer chains to orientate. 
The result is longer and stronger fibrillated billet that is suitable for machining. Process 
takes hours to complete and is patented proprietary technology developed in Finland.  
Self-reinforcing (also called fibrillation) is performed in controlled cleanroom environ-
ment.  
In-Process quality control consists of following tests: Determination of shear strength, 
measuring of the billet diameter and visual inspection of the billet 
 
 
Figure 7. Billet attached to a drawing sled 
 
3.8.3 Machining / Creation of form 
 
This step the final form of the ImplantX is created. Self-reinforced billet is first peeled 
with peeling equipment, then it is cut into suitable pieces with lathe and instrument hole 
is made. Pieces are then machined in another lathe, where the final form is created. 
Then products go to finishing, which as a result of the lean initiatives, is now located at 
the same production cell then lathe. 
Machining is performed in controlled cleanroom environment.  
In-Process quality control consists of following tests: Dimensional measurement, in-
strument testing and visual inspection. 
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Figure 8. Lathe 
 
 
3.8.4 Washing 
 
Products are cleaned after machining in ultrasonic washing equipment and dried in 
vacuum drying cabinet or in similar device. 
Washing is performed in controlled cleanroom environment. 
 
3.8.5 Packing 
 
Clean and dry products are then taken to packing where product labels are printed then 
products are packed into a holder before being packed and sealed with heat sealing 
equipment into foil pouch. Products are then packed and sealed with heat sealing 
equipment into Tyvek-pouch before setting products into gamma box. 
Packing is performed in controlled cleanroom environment. 
In-Process quality control consists of following tests: Tearing test for foil pouches and 
Tyvek-pouches (visual inspection) and Monthly testing of foil and Tyvek pouches 
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3.8.6 Gamma Packing 
 
Products need to be sterilized in the outside facility, so they need to be packed well for 
the shipment. There is also three different kind of sterilization processes used based on 
the product. So the products are placed in the relevant transportation box with tem-
perature- and Gamma indicators. Finally the transportation box is closed.  
This process step does not require cleanroom environment. 
 
3.8.7 Sterilization 
 
Sterilization is sub-contracted and is performed in sub-contractors facility in Germany. 
Gamma process number 3 is used for ImplantX products.  
In-Process quality control consists of following tests: Irradiation dosimeters 
 
3.8.8 Customer packing 
 
After sterilization final product packaging is done. Product labels are printed and at-
tached to a hospital box. Product pouch, patient label and instruction for use is packed 
into the hospital box. Plastic sleeve is then placed around hospital box. 
This process step does not require cleanroom environment. 
Product is now ready and waiting for release. 
 
3.8.9 Release 
 
Before production Lot can be approved for release Torsion and Shear strength tests 
have to be completed. Quality engineer then signs the required release documentation 
and product is ready for shipping to distribution centers.   
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3.9 Injection moulding process 
 
Injection moulded ImplantX has 35 different sizes. Process includes compounding, 
cutting and injection moulding. 
 
COMPOUNDING
PELLETIZING
Drying of raw material
Compounding
Pelletizing
Injection Moulding
Drying of masterbatch pellets
Injection moulding
PACKING
Printing of labels
Packing to a holder
Packing and sealing of foil pouches
Packing and sealing of Tyvek-pouches
Placing of Tyvek pouch to a gamma box
STERILIZATION
Sterilization sub-contracted
RELEASE
Lot Approval
Customer Packing
Packaging of sealed products, patient 
labels and IFUs to Hospital boxes
Gamma Packing
Gamma Packing
Closing of transporation box
 
Figure 9. ImplantX Injection Moulded manufacturing process 
 
3.9.1 Compounding and Pelletizing 
In this step composite material billets are manufactured from raw materials by continu-
ously mixing bioactive ceramic (β –TCP) to biodegradable polymer (96L/4D PLA) using 
twin-screw extruder applied in the machined process. Billet is then pelletized (cut) in 
masterbatch pellets of pre-defined size. Masterbatch is a blend of polymer and additive 
(ceramic) used as granulate raw material in injection moulding machine. 
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Process is done in controlled cleanroom environment. Sub-process steps consist of 
drying of raw materials in vacuum oven, compounding them in twin-screw extruder and 
pelletizing with pelletizing equipment. 
 
In-Process quality control consists of following tests: Measurement of pellet dimen-
sions, Measurement of TCP-content, Measurement of inherent viscosity, determination 
of monomer content and Visual inspection of the billet. 
 
3.9.2 Injection Moulding 
 
The final form of the ImplantX is created in this step. The masterbatch pellets are dried 
in vacuum oven or with hot-air dryer. Pellets are then heated to a liquid state and in-
jected into the mould using Injection moulding machine. Ready pieces are removed 
from the mould and sent to packing. Each product size needs their own mould, so 
mould needs to be changed every time a different product size is manufactured. 
Injection moulding is performed in controlled cleanroom environment.  
 
In-Process quality control consists of following tests: Dimensional measurement, 
Measurement of inherent viscosity and determination of monomer content. 
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Figure 10. Injection moulding machine 
 
3.9.3 Packing, Sterilization and Release 
Packing, gamma packing, sterilization, customer packing and release processes are 
the same as for Machined manufacturing process 
 
3.10 Summary 
 
When reviewing a transfer case it shows that there are many variables in the transfer 
project and even if the US based company has done manufacturing relocation transfers 
before, there was no template that could be used in the International transfer. They 
also encountered some issues that came as a surprise especially in regulatory field. 
Project plan also had major changes after transfer operations started. Communication 
of the transfer progress and processing project plan changes is a challenge.  In this 
sense pre-transfer planning seem very important identifying variables and risks associ-
ated with the transfer. Ample safety stocks allow time to address these issues, but 
strain resources in sending organization. Local transfer project manager was essential 
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in coordinating the transfer project with overall project manager. On-hand training at 
the manufacturing floor seemed to be effective method of transferring manufacturing 
knowledge if the trainee had previous experience in similar processes and willingness 
to learn. Some manufacturing steps are more challenging than others making 
knowledge transfer of these steps a challenge. It seems that if the product manufactur-
ing process has been strictly validated and documented, it is easier to transfer. Older 
OPF products have not been re-validated for years, so work and equipment instruc-
tions are not as detailed as the newer product instructions. Operator then relies more in 
the personal experience than instructions. Compounding and Self-Reinforcement pro-
cess steps seem to be most difficult and time consuming to transfer. Custom made 
machinery is used in these steps, which makes operating and maintenance a chal-
lenge. It also appears that if the manufacturing process is transferred as it is, without 
changes, there is a higher change of a success and less issues. Cultural and language 
issues effect the transfer, but no major issues were encountered. Different hierarchy in 
receiving site can cause issues when trying to keep the process same as in OPF. 
Some adaptation may be necessary. Rsite2 had no previous experience working with 
biomaterial implants, so they had more challenges compared to Rsite1, which had 
some experience. Retaining OPF personnel with the bonus seemed to be a successful 
way in motivating and preserving valuable human resources during the transfer project.  
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4 Best Practices on manufacturing relocation based on existing relevant 
literature 
 
Literature on medical device manufacturing transfers is scarce concentrating on trans-
fers from research and development to manufacturing or outsourcing instead of manu-
facturing location transfers. Some literature about international technology and 
knowledge transfer in general is available and there are companies that provide trans-
fer service or outsourcing for medical industry like Creganna-Tactx Medical and Advant 
medical.  
 
As many as two-thirds of all relocations by manufacturing operations turn out to 
be ill advised, says Walter E. Kemp, a Vice President with Michael Paris Associ-
ates (MPA). Relocation blunders can be avoided with comprehensive -- and can-
did -- evaluations. (Relocation:Risky Business 1999) 
 
In 1976 David J. Teece from Stanford University researched 26 technological transfer 
projects from chemical/petroleum refining and machinery industries in attempt to count 
the total cost of the transfer. His research revealed that the transfer costs vary consid-
erably and it is not possible to make generalizations of costs involved. One observation 
he made was that costs decline the more times innovation is applied. Transfer is less 
costly and easier if the technology is mature. One example could be the transfer of a 
hamburger restaurant. It can be considered easier because raw-materials, equipment 
and skilled labor is widely available compared to biodegradable implant manufacturing 
with special raw-materials, custom equipment and limited availability of skilled labor. 
Each case seem to be different which makes manufacturing transfers a challenging 
area to study. 
Visits to sending organization at an early stage of the transfer project and hands-on- 
training is important, “Pull” –type of technology transfers seem most successful model 
according to Klaus North. “Pull” -type allows recipients to decide which technologies to 
apply. Competent managers on the recipient side is requisite for successful transfer.  
 
Traditionally, the strategic assessment of potential manufacturing transfers con-
centrates on financial and legal (contractual) issues alone. This analysis is fre-
quently static and based only on a limited range of variables, such as the cost of 
a single factor. Considerably less emphasis is placed initially on the alignment 
between potential partners manufacturing capabilities, or the identification of 
possible difficulties arising from the technological and manufacturing systems in 
use. In addition, subtle, though no less important, social, political and cultural as-
pects are usually not recognised in the early stages of a project. As a result, 
product transfers are frequently more troublesome, time-consuming and costly 
than originally planned (Tim Minshall and Andrew Steele). 
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Tim Minshall and Andrew Steele have developed manufactured manufacturing transfer 
process at Cambridge University.  
 
Strategy making Exploring
Evaluating and 
Assessing
Packaging and 
Adapting
Transferring Embedding
Feeding back
 
Figure 11. T. Minshall and A. Steele Manufacturing transfer process  
 
Strategy making step includes setting business objectives. Exploring is identifying po-
tential partners and manufacturing sites. Evaluation and assessing step includes eval-
uating “Fitness for Transfer”, which can be interpret as ability of the potential manufac-
turer. In packaging and adapting step manufacturing transfer package is prepared and 
processes are adapted as necessary for receiving site. In Transferring step actual 
transfer activities begin and embedding phase prepares receiving site for continuous 
manufacturing. Providing Feedback between sites to improve and learn from the trans-
fer project in order to improve future transfers is the last step. 
Minshall and Steele also identify manufacturing decision areas that go through process 
steps described above. Decision areas are facilities, suppliers, material control, Human 
resources, knowledge, organization and relationships, quality and external environ-
ment. 
 
Advant medical company provides manufacturing transfer services and their overall 
transfer process is described below.  
 
Review and Analysis
Transfer Project 
Team
Transfer Plan 
Implementation
Process Installation 
and Optimization
Process Validation 
and Manufacturing 
Transfer
 
Figure 12. Advant Medical Manufacturing transfer process 
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Review and Analysis step consists of review of the scope of the transfer, the timeline 
and costs to develop a precise evaluation of the situation. This is followed by transfer 
project team selection and forming a communication plan. In transfer plan implementa-
tion step a detailed implementation plan is developed including Documentation Control, 
Quality and Risk Management, Human Resources and Training, Equipment Transfer, 
Supply Chain Development, Production Line Development, Sterilization Process and 
Safety Stock Development. In the Process installation and optimization step equipment 
is installed as it is on the sending site and optimized for efficiency. Final step is the pro-
cess validations and actual manufacturing ramp-up. 
 
Creganna-Tactx Medical Company’s transfer process is slightly different consisting in 
total of seven steps.  
 
Project Feasibility Detailed Planning Development Transfer/Install Validation
Manufacturing 
Ramp
Ongoing Operations
 
Figure 13. Creganna-Tactx Medical Manufacturing Transfer Process 
  
Starting step is project feasibility analysis where the goal is to understand objectives 
and requirements, review solutions and develop proposal. Detailed project plan is de-
veloped in the next step followed by development, where product development and 
testing is completed if required. Transfer and installation step equipment and tooling is 
transferred or purchased. Manufacturing lines are setup and IQ (Installation qualifica-
tion) is performed to all equipment. Validation phase includes all operative and perfor-
mance process validations and product validations for finished devices. Manufacturing 
ramp up meeting the required yield and quality targets is done and ongoing operations     
 
4.1 Manufacturing Knowledge transfer on operative level 
 
Manufacturing knowledge transfer is probably one of the most challenging task in the 
manufacturing transfer. Ways to transfer specific know-how according to Klaus North 
Master’s Thesis 
29 (64) 
 
 
are using expatriate managers, training of new personnel in sending facility, purchase 
of same key equipment as in sending facility and creating know-how supply source 
using central planning department. Examples of common knowledge transfer mecha-
nisms are as follows, Joint committees, regular meetings, manuals and documentation, 
quality control, maintenance, standardization and environmental management. One of 
the ways to transfer or a transfer case would include: project team, cooperation with 
equipment vendors and consultants, external training and transfer from simulation/test 
plant to real size. Joint project teams are also mentioned as one of the mechanisms to 
facilitate the transfer. 
A Standard Operation Procedure (SOP) incorporates explicit knowledge derived from 
previous experiences in the codified document form. This procedure however is use-
less until it is actually performed by workers on the manufacturing floor. Workers de-
velop, share and use tacit (hidden) knowledge as they perform their daily tasks. Tacit 
knowledge is regarded as a key competitive resource for companies and has a signifi-
cant role on the manufacturing floor. (Davi Nakano, Jorge Muniz Jr and Edgard Dias 
Batista Jr 2013).  
 
The act of solving a problem rests on a sense of how the phenomena function; 
the formal expression of the solution is unlikely to capture fully this procedural 
knowledge, or even the data and information (or clues, as Polanyi describes it) 
leading to the solution. Thus, even in the arena of problem identification and solv-
ing, the know-how of heuristic search precedes the formal knowledge of the solu-
tion. (Bruce Kogut, Udo Zander 1992) 
 
Biggest barrier for knowledge transfer is lack of recipient absorptive capability   (Szu-
lanski, 1996). There is not a lot of accessible practical knowledge transfer literature 
suitable for manufacturing personnel knowledge transfer. In 2012 a practitioner Calixto 
P.Anaya wrote a book called Knowledge transfer a practical approach, where he de-
scribes knowledge transfer program he has been using throughout his career. He es-
pecially focuses transferring knowledge from senior employees to junior employees. 
Based on his experience, knowledge transfer (KT) can be completed in four years. 
Similar situation is in the case of OPF transfer, at sending organization there are senior 
employees and receiving site has junior employees at least in the terms of knowledge 
in manufacturing of biodegradable implants. The transfer program starts by de-
mographics study, which reveals disciplines affected, what are critical knowledge and 
skills and who are persons that possess these skills. Next step is selecting mentors 
identified by previous step. Mentors are experts that are dedicated to knowledge trans-
fer in their disciplines. Mentors responsibility is the implementation of the KT program 
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in their field of expertise. In step three selected mentors conduct competence surveys 
and map each individuals competence in four levels based on achieved scores. This is 
current state of competence and then targets will be set. Actual knowledge transfer 
activities can then begin using targeted selectively training, on-the-job mentoring, job 
shadowing and using focus groups. Expert interviews can also be conducted in order to 
transfer tacit knowledge. Transfer activities are monitored and reported until goals are 
met. Program can then be shutdown. Inspired by Calixto P. Anaya this research uses a 
survey to uncover the experts, risks, solutions and training estimates. These experts 
are then interviewed in order to identify and capture some of the most critical tacit 
knowledge in each manufacturing step. The OPF transfer was scheduled for 18 
months, so according to Calixto P. Anya this would not be enough time for confident 
knowledge transfer. Some of the knowledge will likely be lost during the transfer. 
 
4.2 Cultural transfer aspects 
 
Culture refers to the collective beliefs and values widely shared in specific society 
among persons at certain point of time (Ralston 1993). Culture can be found at differ-
ent levels such as the country level and the corporate level. Transfer of knowledge 
study by Bhagat in 2002 has shown that cultural differences cause major challenges 
when transferring knowledge across borders. In 1997 Klaus North found evidence in 
his research of international transfers that the corporate culture determines more than 
the host country culture with know-how suppliers and recipients priorities. According to 
Hofstede (1980), every country has its own distinctive national culture. It is important to 
consider how differences in the national culture dimensions between a subsidiary and 
parent company effect the transfer. 
In 1980 Hofstede identified four dimensions along which national cultures tended to 
differ: Power distance – expectations and acceptance of inequality of power distribu-
tion, Individualism/collectivism – importance of individual goals versus collective goals, 
Uncertainty avoidance – Acceptance or defense against future possibilities, and Mas-
culinity/ femininity – Gender based dominant values of society. 
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4.3 Conceptual framework 
 
Based on the review of the case analysis and relevant literature author has formed a 
conceptual framework of items that contribute to the successful transfer which are 
shown in the figure below. Overall Transfer items interact with decision variables and 
barriers or driving factors of the transfer. These factors contribute the success or failure 
of the transfer. Examples of decision variables are the target location of the transfer, 
regulatory requirements, knowledge transfer and maturity of technology. Knowledge 
transfer is probably the most challenging item in the transfer. With each decision varia-
ble project management has to develop strategy, methods and assign resources in 
order to successfully process each item. Barriers and driving factors interact with trans-
fer and variables either helping or hindering progress. Major cultural differences are 
usually hindering factors in the transfer and extensive previous experience is one of 
driving factors. 
 
Figure 14. Conceptual Framework 
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In the figure below, the Manufacturing Knowledge circle represents the total amount of 
manufacturing knowledge that needs to be transferred. Driving factors are pushing cir-
cle inside the transfer circle. Barriers of knowledge transfer, a lack of absorptive capa-
bility for example, hinder the knowledge transfer.  
 
Figure 15. Conceptual framework of the Manufacturing knowledge transfer decision variable 
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5 Building proposal for the case company 
 
5.1 Best Practices Process 
 
This best practices process has been compiled from case analyses, relevant literature 
and expert interviews, using especially points where interviewees described how they 
would have done the transfer if they had the power to decide. The process starts at the 
point when senior management has already decided that manufacturing relocation 
should be started. 
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Figure 16. Best Practices process proposal 
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5.1.1 Decision to transfer 
 
Senior management has become to conclusion that change is needed and they initiate 
the transfer project and appoint responsible persons into project team. Project team 
should have members from receiving and sending organizations including project man-
agers. Project goals or targets are set by senior management. 
 
The primary goal is the make a seamless transfer with minimal impact to stakeholders 
and also achieve financial and operative goals of the transfer. 
 
5.1.2 Pre-Transfer Planning 
 
Project team members should conduct pre-transfer planning and current state analysis, 
before any actual transfer operations begin by analyzing effect of the decision varia-
bles. These variables effect risk level and schedule of the transfer. Kimberly Murdoch 
suggests creation of the cause and effect diagram based on the risk contributors and 
process elements like methods and machines in order to uncover potential risks.  
 
Decision variables involved in transfer mentioned by Benita M. Beamon (1998) with 
input from interviews are described below. List is not exhaustive and project managers 
could add variables in case they have significant effect on the transfer. 
 
Scope/Product families:  Determining the number of different product  
  families that will be transferred and have any  
  finished goods inventory. Discontinuation of products. 
Manufacturing Process What methods of manufacturing and processes are used? 
Maturity of the technology Evaluate if the technology and methods used are common. 
Number of Steps  Determining the number of steps that will comprise supply 
  chain. This involves changing the chains level of vertical 
  integration by removing or adding steps. 
Plant  Determining which manufacturing plants will manufacture 
  products, necessary facility improvements and environment.  
Distribution Center (DC) - Determining which DCs will serve which customer segments. 
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Purchasing   Determining and developing critical aspects of the buyer-
  supplier relationship. 
Inventory   Determining the amount and location of raw material, sub
  assembly, and final assembly storage. 
Scheduling   Scheduling the manufacturing and/or distribution. 
Regulatory  Regulatory impact, Submission time and cost 
Quality Assurance Documentation, work/equipment and measuring instruc-
tions, measuring and release procedures. Translations. 
Knowledge transfer Absorptive capability estimation, Skills transfer, training and 
  technical support 
Equipment  Office/Manufacturing equipment and tools 
Software and Data Migration of licenses, files and other data from computer 
  systems 
R&D/Patents/Contracts Any R&D, patents or long term contracts in sending location 
Human resources Retention/hiring of personnel in sending and receiving 
  location. 
 
 
Determination of what products there are in sending location is the first step. This in-
cludes the amount of products, product families and catalogue numbers. How many 
are components versus final products manufactured and the manufacturing meth-
ods/processes used, in this case machined or injection moulded.  
Sales data needs to be reviewed. If there is longer regulatory time period like in Korea 
for example. What percentage of the product is actually sold in that market? Sales per-
centage product/family in all the different markets is reviewed and regulatory impacts 
they would have. Some products/families may have to be considered for discontinua-
tion, if for example a product is sold primarily in China and has very low profit margins 
and would take a long time to get resubmitted to regulatory approval. Analysis of what 
would be the total cost of transferring, how long would it take to actually make that 
money back should be done for each product/family using cost-benefit analyses. Prod-
ucts that have very low profit margin and high cost of transfer should be considered for 
discontinuation. 
Good practice is to create a flow chart of product family characteristics and then try to 
determine the best supply chain structure. What would be the best manufacturing loca-
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tion, in this case either Rsite1 or Rsite2, based on each locations expertise and suita-
bility?  
Raw materials and other materials like packaging and labelling need to be sourced 
preferable locally. In the case of very specific materials, sourcing locally may not be an 
option and this has to be taken into account in lead time. OPF sourced raw materials 
from Europe from two certified and validated suppliers. The relationship building with 
those suppliers and their representatives in US is crucial. 
The maturity of the technology and uniqueness of the products needs to be evaluated. 
If the equipment and manufacturing methods used in sending location are common and 
skilled labor is available in receiving location, the transfer is probably easier.  
Any changes to manufacturing steps, methods, processes and quality control should 
be done in sending location before the transfer. Injection moulded process changes 
were finished in Finland before transferring the manufacturing to US and initial results 
of the transfer were positive. Chances made in receiving location would add unknown 
risks to manufacturing, which has been experienced with other transferred products. It 
is not recommended to split process into two or more sections. For example billets 
made in different factory and shipped across country for final processing in another 
would create a gap in feedback of possible defect billets. Receiving location should first 
have a solid understanding about the product, before conducting any changes to 
manufacturing steps, methods, processes or quality control.  
There is a need to build up more inventory of products transferred because there prob-
ably is going to be a time period, were there is no manufacturing being done in any 
location. Planning is needed from inventory standpoint, of how much safety stock is 
needed to cover transfer periods. Sending organization will have to make extra prod-
ucts and that affects the transfer schedule. Sending organization will be requested to 
make for example 10 months’ worth of extra inventory, which requires additional 
schedule and resource planning in sending location. 
Company operates in medical industry, so there is also regulatory impact from the 
transfer. There are differences if the final products are made in US or in Europe. If the 
transfer is considered a major change or not from regulatory stand point and how long 
regulatory submissions will affect the decision on the size of the safety stocks.  
All the product documentation, which is in paper or electronic form, has to transferred 
and in most cases translated from Finnish to English, in this case. This includes work-, 
QA- and equipment instructions. These documents describe how the products are 
manufactured and equipment is operated. The time this takes depends on the amount 
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of products. It took more than a year to complete documentation transfer in OPF trans-
fer with about 400 products. Regulatory related documentation like release documents 
need to be transferred to an archive according to archiving requirements of FDA and 
other governmental regulatory bodies. 
Products made in OPF Finland are unique and require special manufacturing 
knowledge beyond what is found in documentation. This knowledge has to be trans-
ferred to the receiving site, in order for them to be able to effectively manufacture the 
products. Knowledge transfer should include engineering knowledge in addition to op-
erational knowledge to get a better understanding of the complete manufacturing pro-
cess. Knowledge transfer should be a documented process following knowledge trans-
fer process of Calixto P. Anaya for example, where knowledge holders are uncovered 
by a survey and used as mentors in a documented training program.  
  
Sending site usually has ERP system from where the data can be migrated to receiving 
organizations ERP system. In this case ERP system was same in Rsite1, so migration 
there was easy. Rsite2 uses a different ERP system, so all the Bill of Materials, rout-
ings, resources have to be input into their system (Manually or with automated tools). 
Data files need to be copied and sent to receiving site. Legal issues need to be taken 
into account especially regarding personal files and email archives. Data amounts can 
be very large (Terabytes), so transfer using encrypted external hard drive or backup 
tapes media is recommended if the network connection speed between sites is less 
than 100Mbps. 
Result of the planning activities should be project plan, which would then be presented 
to senior management for approval. 
 
Proposed supply chain structure for receiving sites is described in the figure below. 
Subcontracting semi-finished components to other units is not recommended at the 
beginning for the biomaterial implant components due to risk of increased scrap cost in 
case of faulty batches. This can be done when component manufacturing process is 
stable and manufacturing experience is cumulated at the manufacturing site. Raw ma-
terials and moulds can be sourced from Europe at the beginning, but it is recommend-
ed that local approved suppliers are used if available. 
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Figure 17. Proposed Supply Chain Structure  
 
5.1.3 Reassessment 
 
After planning step risk analyses and re-evaluation of the transfer is recommended by 
senior management, answering questions like: Can the goals be achieved with the 
transfer when this more complete information is taken into account? Are the risks too 
high and how they can be mitigated? Senior management would reassess and confirm 
the original decision, modify or cancel. Some products originally included in the transfer 
goals could be discontinued for example. Senior management would set Goals, meas-
urements and key performance indicators, which will be used to monitor transfer per-
formance. They would accept transfer project plan and actual transfer operations would 
start. 
 
5.1.4 Measurements and KPIs 
 
Most important KPIs are the customer complaint figures, scrap rate, manufacturing cost 
and number of backorders. KPI measurement data collected in OPF is comparable to 
data from other US based company manufacturing units, so it is possible to evaluate 
receiving site manufacturing unit performance after manufacturing transfer is complet-
ed in comparison with the historical data of OPF.  Success of the transfer project can 
be measured by comparing initial transfer schedule/budget to actual costs and sched-
ule.  Raise in customer complaint or in scrap rate would indicate issues. Manufacturing 
yield, cost and backorders show the level of operational efficiency. 
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US based company uses SQDC (Safety, Quality, Delivery and Cost) strategy to meas-
ure its manufacturing performance. A big SQDC board is located at near the rest areas, 
so everyone can see the performance levels. Quality department is responsible in up-
dating information on the board. US based company also uses earned hours as a way 
to evaluate manufacturing efficiency. Earned hours is traditional way of looking perfor-
mance, because results depend heavily on cycle time parameter setup for products. 
Those parameter have to be kept up to date or the reports will show incorrect data. In 
this sense adding the reporting of the manufacturing cost and yield would provide more 
comprehensive results.  
Data collected in these KPIs (Key Performance Indicators) includes safety measures 
indicating accident free days and cleanliness. Quality key performance indicators like 
product scrap amounts and scrap percentage per month (actual vs. target). Delivery 
KPIs include demand vs. monthly produced pieces. Cost measures show cumulative 
scrap in agreed currency and Operational expenditure (actual vs. budgeted). Finance 
department is responsible of the following items: investments, budgeted expenses ver-
sus actual and other management accounting activities. US Based company also 
measures customer complaints and back-orders. This information is provided to US 
subsidiary clinical and customer service personnel. Customer complaints have to be 
processed according to regulatory guidelines. 
 
Listed below are examples of high level performance measures and goals that can be 
used in the transfer project (Benita m. Beamon 1998). 
 
Cost    Minimize cost, Minimize average inventory 
   levels, Maximize profit, Minimize amount of 
   obsolete inventory 
Customer Responsiveness Achieve target service level (fill rate), Minimize 
   stockout probability 
   Minimize product demand variance or 
   demand amplification, Maximize buyer-supplier 
   benefit.  
  
Activity  Time, Minimize the number of activity days and 
 total cost, Flexibility, 
Maximize available system capacity. 
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5.1.5 Transfer operations 
 
Transfer involves people in many departments and for the responsibilities to be clear   
roles are needed.  Roles should be set for every significant manufacturing step and 
related support functions. Uncovered experts should be assigned to mentor roles and 
personnel coming for the training in trainee roles given an example. Responsibilities 
should be clear for everyone. 
Transfer order needs to be decided. US based company decided to move from back to 
front. Meaning that last production steps (machining, packing and injection moulding) 
were transferred first. Compounding and pelletizing steps were last to be transferred. 
The majority of interviewees saw this as a proper order of the transfer, minimizing safe-
ty stock needs and allowing more time to learn challenging compounding and pelletiz-
ing steps. 
 Risks can be mitigated by having experienced engineers and operators spend time at 
sending location as much as possible, doing hands on training with experienced men-
tors and also by trying to maintain a good relationship with engineers that might agree 
to help even after the transfer is complete. Expert visits from sending location to receiv-
ing location and offering a consulting or expatriate contracts to key persons will help at 
the beginning of the production and mitigation of risks. Persons chosen for the trainee 
roles should have previous experience in similar field and other positive character 
trades in order to have good absorptive capability. 
Decision variables in planning step have turned into action steps in the transfer project 
plan. These actions will be performed according to project plan, including the actual 
transfer operations like building safety stocks, translating documentation, submitting 
regulatory approvals, training and equipment relocation to name a few. 
Transfer progress should monitored and communicated to the personnel in both send-
ing and receiving organizations. Communication plan created in planning step should 
be followed and project managers should always be informed (copied) even in one-to-
one information exchange concerning the transfer topics. Any corrective actions like 
changes to project plan or responses to emerged issues should be done through con-
trolled documented process. 
In the receiving site the process validations will have to be completed before manufac-
turing can begin including IQ (Installation qualification), OQ (Operational Qualification) 
and PQ (Performance Qualification). After all the required steps and regulatory issues 
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have been solved the manufacturing can be initiated in the new location. Experts from 
the sending site are especially valuable in steps mentioned above. 
 
5.1.6 Transfer close and review 
 
Manufacturing transfer is a project, which comes to an end at some point. Senior man-
agement will make decision to close the project and review the results. Some of the 
results will be revealed later like customer feedback and long term operational perfor-
mance. In this sense it would be good to revisit the results maybe two years later and 
compare the results. Lessons learned session is a good venue to discuss and analyze 
the issues and successes encountered during the project, so they can be taken into 
account in the next transfer project. 
 
5.2 Required knowledge level for Manufacturing Process steps 
 
Manufacturing knowledge transfer is one of the most challenging items in the transfer 
variables. Therefore it is recommended that each process step is studied in order to 
assess knowledge transfer difficulty and estimated training time. 
  
Compounding biomaterial with twin-screw extruder is one of the most challenging pro-
cesses in OPF. Majority of the personnel have over 20 years of experience in com-
pounding composite biodegradable materials into billets and this is a rare process in 
medical device industry.  Based on the survey results and expert interviews it takes 
experienced (50%) or Expert (50%) with years of experience to perform and to be 
trained for this process step. Interviewed expert estimated that five years previous ex-
perience in extrusion would be required for successful knowledge transfer, which would 
take months. According to the survey 67% estimated it takes months to train an experi-
enced person and for 27% it would take years for the person to perform operational 
tasks independently. Two experts of this process were identified by the survey. Pelletiz-
ing process where extruded billet is cut into pre-defined pieces for use as raw-material 
in injection moulding requires experienced person. Training a person for this process 
takes months and one expert was uncovered by the survey. 
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Self-reinforcement process is proprietary process developed in OPF and is unique in 
the medical industry. Equipment used in the process is custom made. Operators have 
years of experience in this process. In process speed and temperature adjustments are 
made by experienced operator in order to produce quality product. Experienced opera-
tor needs hands-on training of several months to independently run the process ac-
cording to the survey and interviewed expert. Two experts were uncovered by the sur-
vey. ImplantX process parameters are better validated and more precise then other 
OPF products, because of three stone system. For this reason the skills acquired in 
ImplantX self-reinforcement process are not directly applicable to other self-reinforced 
products.  
 
Machining process step is performed using commonly available lathes, but it still needs 
experienced person to train weeks (45%) or months (45%) to be able independently 
perform needed process steps mostly due to material used. Interviewed expert esti-
mated two to three months hand-on training time would be adequate for experienced 
machinist. This would allow enough practice to get used to the raw-material billets, tool 
and product changes including some minor troubleshooting. One expert was uncov-
ered in the survey.  
 
Finishing is done after product has been created in the lathe at the same production 
cell. It is checked, finished and cleaned. Finishing is in some cases done by surgical 
blade, which is used to remove burrs. Other equipment used is standard industrial ul-
trasonic washer and drying cabinet. This process step requires eye and hand coordina-
tion, and some previous practical experience. Estimated training time on average is few 
weeks. Two experts were uncovered by the survey. 
 
Injection moulding is another way of manufacturing the product. This step comes after 
compounding and pelletizing steps. Injection moulding equipment used are standard 
injection moulding machines common in plastics industry. Moulds and related parts are 
custom made in Finland. ImplantX has 35 moulds and they are run with two different 
parameter sets according to the size of the product. This requires less validation runs 
against doing validation runs individually for each 35 moulds. Majority of the survey 
respondents (70%) estimate that experienced person is needed for this step and it 
would take months to train. Person with no experience of the injection moulding takes 
about one year to be able independently perform this process step. According to the 
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expert uncovered by the survey, for experienced injection moulding operator hands-on 
training with mentor takes estimated two months. 
 
In packing step the product is placed into product pouches and sealed. This process 
step is very similar to all OPF products and does not require a lot of experience. Most 
respondents agree that days or weeks training is enough to perform this process step. 
Three experts were found with one receiving the majority of mentions.  
 
Products are packed and sent for sterilization in this gamma packing step. No long ex-
perience is required, however training takes average of weeks to complete. Survey 
respondents were quite divided in this step 40% agreeing that training would only take 
days and 40% that it would take months. 
 
Sterilization step is outsourced to supplier in Germany. The equipment and facilities 
required are very special. Person receiving back the sterilized products needs to have 
years of experience and months or years of training in order to verify the validity of the 
product batch. One expert was found by the survey and she has over 25 years of expe-
rience. 
 
In the customer packing step the sterilized product is placed into final customer boxes 
with instructions for use. This step doesn’t require a lot of experience, and training for a 
new person would take few weeks on average. 
 
In Release step the products are released for delivery after quality assurance has 
made sure that they fulfil all the requirements. This step requires experienced (56%) or 
expert (44%) person to perform this step correctly and it would take months to years of 
training. One expert was uncovered by the survey. 
 
Laboratory is responsible for most of the key in-process measurements in each manu-
facturing step. It would take experienced person months to learn how to perform these 
measurements. Equipment used is standard laboratory equipment available in most 
countries. Measuring processes are the same for the different products, so if the per-
son can perform ImplantX measurements he/she can also perform measurements for 
other products as well. Two main experts were uncovered by the survey. 
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5.3 Manufacturing process issues and Risk Analysis 
 
Research results presented below are based on expert interviews and survey results. 
Manufacturing steps require different levels of experience and training. Persons previ-
ous experience significantly reduces training time needed. Experienced injection 
moulding operator can be trained in two months, but person with no previous experi-
ence in injection moulding would take 12 months according to interviewed expert. This 
time does not include problem solving skills. Manufacturing process in Finland subsidi-
ary has been improved over the years due to operators gaining more experience and 
with corrective and preventive actions (CAPA process). Possibility of the risks have 
been mitigated and issues are generally encountered rarely. According to the inter-
views, likelihood of the risks will increase if the process is changed and/or operator is 
inexperienced. The issues encountered according to the survey are listed in the follow-
ing paragraphs and risk factor has been calculated adding scores of probability, severi-
ty and how easily issue is detected. Each point has score from 1-4, where 4 is the 
highest. If many responders brought up the same issue the average from each value 
was calculated. Maximum score is 12 which indicates a highest risk priority. Risk factor 
below 6 points indicates low risk priority and 9 points or more indicates high risk priori-
ty. According to results there were no high risk priority issues in OPF and maximum 
score obtained was 8, which indicates medium risk priority. Table 1. shows the possible 
answers. 
 
Poikkeaman toteutuminen  
Probability 
Riskitaso 
Severity 
Poikkeaman havaittavuus 
Detectability 
1.Tapahtuu harvoin (1/vuosi)  
   Occurs rarely (1/year) 
1. Vähäinen 
    Minor 
1. Helposti havaittava 
   Easily detectable 
2. Tapahtuu melko harvoin (1/kk) 
    Occurs quite rarely (1/Mo) 
2. Kohtalainen 
   Moderate 
2.Kohtalaisen helposti ha-
vaittava  
Quite easily detectable 
3. Tapahtuu melko usein (1/vko) 
    Occurs Quite frequently (1/vko) 
3. Vakava  
    Serious 
3. Ei helposti havaittava 
    Not easily detectable 
4. Tapahtuu usein (1/pv) 
    Occurs frequently (1/day) 
4.Kriittinen  
   Critical 
4. Vaikeasti havaittavissa 
    Difficult to detect 
Table 1. Risk Analysis choices and scores in Survey 
  
Analysis method is based on the training by the center for professional innovation and 
education in 2011 and is adapted from GAMP risk assessment method. The purpose is 
to identify and apply measures on high risk priority issues.   
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5.3.1 Compounding  
 
The most common error situations in compounding (extrusion) are sensor malfunction, 
production run failing using validated parameters, feeder malfunction and raw-material 
issues or contamination. Most of the issues occur rarely with experienced operators, 
maybe once per month, and are quite evident. Exception are the material issues which 
are only uncovered in laboratory measurements. Common Pelletizing errors in material 
are too low or high internal viscosity or contamination, which are visually hard to detect 
and require laboratory measurements. Pelletizing machine may produce une-
ven/various length pellets or malfunctions. Incorrect parameters also cause issues. 
Most of the issues occur very rarely (few times in a year) for experienced operators and 
are detected with ease except material related issues. Pellet material is not clear be-
cause of the additive, so contamination issues are visually hard to detect.  
 
Compounding is the first step in ImplantX manufacturing and one of the most challeng-
ing. Inexperienced operator could assemble manufacturing equipment incorrectly. This 
could lead to machine breakage or fire in the worst case scenario. Scale equipment is 
very sensitive and prone to errors and could cause so-called displacement increment 
(reaping), where results are slowly moving toward some direction eventually going un-
der or over approved limits. These issues are detected in laboratory incineration tests. 
Common issues are related to software. Compounding cell is a system of many ma-
chines working together, so operators/maintenance personnel needs to be familiar with 
the machines working together as complete system (cell). Equipment and raw-material 
suppliers can help, but they will only be of assistance for their provided machinery or 
material not the whole cell. Risk in depending too much on this, is that equipment man-
ufacturer could confirm that their machine or device is working and raw-material suppli-
er confirms that material is valid, but the cell still doesn’t output valid products. Problem 
solving, after support from sending site is no longer available, is a major risk especially 
when training is focused mostly on actual day to day operations with limited or no on-
site troubleshooting activities. With only limited number of persons attending the train-
ings, the receiving site manufacturing knowledge is focused in these persons and 
should they decide to leave the company before transfer is completed or shortly after-
wards is a major risk. 
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Manufacturing process in Finland subsidiary has been improved over the years and 
possibility of the risks have been mitigated. Issues are generally encountered rarely. 
Table 2. shows the list of issues and calculated risk factor from the survey in com-
pounding step and Table 3. In pelletizing step. 
Table 2. Deviation/error situations in Compounding 
  
 
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Contamination 
Dirt or foreign particles in the 
pellet. Detecting contamination is 
challenging, because pellets are 
not see-through due to MicroTCP 
additive.  
1 3 4 8 
Pellet IV too 
high or low  
Internal viscosity is out of toler-
ance. 
1 2 2 5 
Equipment 
produces de-
fect pellets, 
especially the 
length can 
vary. 
Pellet lengths are constantly 
measured and monitored, so 
defect is detected quite easily.  
2,5 1 1,5 5 
Incorrect pa-
rameters 
Pellets are not according to spec-
ifications 
2 1 1 4 
Table 3. Deviation/error situations in Pelletizing 
 
 
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Feeder mal-
function. Add-
ing additive is 
not working. 
Material is highly powdery and 
sometimes causes feeder to 
malfunction. Billet has then no 
microTCP component. It can be 
visible detected from the billet. 
There is no feeder alarm and 
noise level in the production 
usually prevents operator to 
hear the noise that feeder 
makes when it malfunctions.   
2 3 2 7 
Sensor mal-
function 
System alarms of defect sensor 1 2 2 5 
Raw-Material 
issues and 
contamination 
Issue with raw-material is un-
covered in the production phase 
or in laboratory measurements 
2 2 1 5 
Production run 
using validated 
parameters not 
possible 
Product does not fulfill approved 
specifications or next production 
step fails. Issue is discovered in 
laboratory measurements. 
1 2 1 4 
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5.3.2 Self-Reinforcement 
 
Common error situations include billet diameter being out of tolerance, shearing 
strength or other mechanical properties are out of tolerance, self-reinforcement is fail-
ing using validated parameters and poor billet surface quality. Issues are encountered 
monthly.  
Troubleshooting and lack of tacit knowledge are risks in this proprietary process. Work 
instructions are not detailed enough to solve issues and to get the feel of the process. 
Major risk arises when only one or two persons in receiving site are familiar with the 
process. Measurements are needed quickly after adjusting temperature or draw ratio in 
order to verify the product properties, so measuring equipment or service needs to be 
readily accessible or there might be extensive scrap if the measurements indicating 
issues are delayed, arriving in next shift for example. Changes to in-process measure-
ment would constitute a risk, In OPF, operator does some of these measurements, so 
there is instant feedback and low level of scrap. 
 
 
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Billet shearing 
strength too 
low or other 
mechanical 
properties out 
of tolerance. 
Mechanical properties out of 
acceptable limits detected by 
laboratory measurements. 
1,5 3 1,5 6 
Billet surface 
quality poor 
Product surface quality is not 
acceptable, detected by operator 
2 2 1 5 
Reinforcement 
process cannot 
be run with 
validated pa-
rameters 
No valid billet by using validated 
parameters  
1 2 1 4 
Billet diameter 
out of toler-
ance 
Billet diameter either too small or 
too high. Defect detected by 
measurements.  
1,33 1,33 1,33 4 
Table 4. Deviation/error situations in Self-reinforcement 
 
 
 
 
 
Master’s Thesis 
48 (64) 
 
 
5.3.3 Peeling, Cutting, Machining 
 
Common issues include product being out of tolerance, no instrument hole or hole out 
of tolerance, incorrect parameters, fractures, contamination, insufficient measurements 
or equipment malfunctions. Issues are encountered weekly or monthly according to the 
survey.   
Machining can cause burrs in the product and this depends on the tools used and order 
of machining. More burr the product has, the more time it takes to finish the product in 
the finishing step. Measurements can also be hard to take. In OPF, the machinist takes 
measurements and is responsible that the products are within specified tolerances, if 
machinist has not been properly trained to take these measurements, there is risk for 
extensive scrap.  
Material is difficult to process, because material properties can vary between different 
billet batches. High quality special tools may be difficult to acquire, because they have 
been designed and manufactured in Finland. Products with fractures that cannot be 
detected may slip through QA causing a possible breakage during installation of the 
product. These occurrences are quite rare.  
  
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Out of toler-
ance 
Product measurements out of 
tolerance, commonly cause is 
incorrect parameters, incomplete 
work instructions or incorrect 
procedure. Deviation is usually 
detected in the production step.  
2,5 2 2 6,5 
Missing mea-
surements 
After parameter adjustment some 
measurements have been omit-
ted by machinist. Deviation is 
detected at the latest in release 
step causing extensive additional 
work and potential scrap. 
2,33 1,33 2,5 6,16 
Fractures Fractures visible in the product 2 2 2 6 
Contamination 
Contamination, dirt or foreign 
particles detected 
2 2 2 6 
Equipment 
malfunction 
Product cannot be manufactured 
if equipment is malfunctioning. 
2 2 1 5 
Insert issue or 
insert hole off-
centre 
Failure in making an Insert hole. 
Could also lead to tool breakage 
and extensive manufacturing 
downtime. 
1,5 1,5 1,5 4,5 
Burr in pro-
ducts 
Products may have extensive 
burrs after machining, which pre-
vent accurate measurements in 
production step. 
2 1 1 4 
Table 5. Deviation/error situations in Machining 
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5.3.4 Finishing 
 
The most common issues encountered are too high paraffin oil content, unfinished or 
un-cleaned product, product cannot be properly cleaned, visible burrs and drying fail-
ure. Products with burrs are encountered weekly, other issues a few times in a year.   
Measurements can be omitted by human error.  
 
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Paraffin con-
tent too high 
After washing, Paraffin oil in the 
product. Paraffin oil content is not 
measured, so detection is diffi-
cult. There is issues with equip-
ment or process.  
1 2 4 7 
Unfinished 
product goes 
to next manu-
facturing step 
Human error in finishing and all 
or part of the product is not fin-
ished. 
1 1 4 6 
Burrs in the 
product 
Product not properly finished. 
Defect detected in inspection. 
3 2 1 6 
Product cannot 
be cleaned 
Product not clean and is detected 
during inspection. 
1 2 2 5 
Product is not 
dry 
Product is wet or moist after dry-
ing. Incorrect drying parameters. 
1 2 2 5 
Table 6. Deviation/error situations in Finishing 
 
5.3.5 Injection Moulding 
 
Issues encountered are contamination, suction on the base, measurements out of tol-
erance, malformed instrument hole, insufficient physical properties and scale feeder 
(Gatetron) malfunction. Most issues occur rarely (once a month) and aside from con-
tamination are fairly easy to detect. Scale feeder issues occur more frequently even 
daily sometimes.  
 
Instrument hole in the bigger products has had issues that the instrument used in in-
stallation does not go all the way inside the product. This can cause product breakage 
during installation by the surgeon. Feeder (Gatetron) errors have occurred in OPF. One 
issue is dirt, which can come after maintenance is done for the mould. Mould is 
cleaned and some grease is applied. Grease is harmless and small amounts could 
exist with no harm. However OPF quality specifications state that there should be no 
Master’s Thesis 
50 (64) 
 
 
grease at all, so some products can have grease at the beginning of the run after 
mould maintenance. Power outage is a risk for continuous manufacturing if the outage 
is 10 minutes or longer. After ten minutes raw material in the cylinder becomes defec-
tive, because internal viscosity and monomer counts collapse, and manufacturing run 
has to be stopped. Mould breakage is another possibility. This has not happened in 
OPF, which shows quality of the moulds, but in case it happens, there are no spare 
moulds available. Lack of troubleshooting experience and only one trained person for 
receiving location is a risk. Risk of a considerable tacit knowledge loss. 
 
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Instrument 
hole defect 
Instrument hole in the product is 
malformed. This is detected with 
instrument gauge. Issue probabil-
ity increases when the size of the 
product grows. 
2 3 2 7 
Contamination 
Dirt or foreign object in the prod-
uct. Due to additive the contami-
nation is not easy to detect. 
2 2 2 6 
Suction at the 
base of the 
product 
Visual defect detected by the 
operator. 
2 1 2 5 
Out of toleran-
ce 
Product out of tolerance. Detect-
ed with dimensional measure-
ments.  
1,5 2 1,5 5 
Physical prop-
erties out of 
tolerance 
Product internal viscosity is too 
low (high) or monomer account is 
too high (low). Detected by labo-
ratory analysis. 
2 2 1 5 
Product defect 
caused by 
mould damage 
Mould is broken. Mould breakage 
could occur if the foreign object 
(metal) enters the mould. 
1 2 2 5 
Table 7. Deviation/error situations in Injection moulding 
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5.3.6 Packing 
 
Issues encountered include poor seal or no seal, contamination (trash or black spot) 
and wrong product in the pouch. Issues are encountered weekly.  
Sealing issues can occur with the thickest products and sometimes the seal has to be 
reworked.  
 
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Seal defective Pouch seal is defective 3 3 2 8 
Pouch is not 
sealed 
Pouch has not been sealed. 1 4 3 8 
Contamination 
in the pouch 
Dirt, black spot or other defect in 
the pouch.  Detected in packing 
or end packing. 
3 2,5 2 7,5 
Incorrect prod-
uct in the 
pouch 
Incorrect product is placed in the 
pouch.  
1 3 2 6 
Table 8. Deviation/error situations in Packing 
 
5.3.7 Gamma Packing 
 
Encountered issues include products sent to wrong Gamma program, sterilization fail-
ure and gamma radiation dose fluctuations. These issues are very rare and encoun-
tered maybe once a year. Products have gamma measurement stickers to verify the 
correct dose. Other issues are hard to detect. Two Experts were uncovered by the sur-
vey. 
 
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Products go to 
incorrect Gamma 
program 
Gamma program used is 
incorrect. Product properties 
can change for example 
internal viscosity 
1 3 3 7 
Gammasterilisa-
tion fails 
Failure is detected from 
Gamma stickers or using 
external laboratory services 
tests (Nelson, bacteria cul-
ture). 
1 3 2 6 
Gamma dose var-
ies 
Packed products receive 
varied gamma doses, if they 
happen to be located at the 
very edges of the process 
area. Product properties can 
be affected. 
1 2 3 6 
Table 9. Deviation/error situations in Gamma Packing 
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5.3.8 Sterilization 
 
Issues encountered are too high bioburden levels (microbes on the product), too Low 
or High Gamma radiation dose and broken package during process. Products have 
gamma measurement stickers to verify the correct dose and broken packages are quite 
easy to detect. Other issues are hard to detect. Fortunately these issues are very rare. 
 
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Bioburden level 
too high. Too low 
Gamma dose 
Bioburden level abnormal. 
Low dose of Gamma3 is not 
enough to sterilize the prod-
uct.  
1 3,5 3 7,5 
Gamma dose too 
high 
Gamma sticker indicates too 
high dose 
1 3 2 6 
Package is broken 
during procedure 
Products are not sterile, be-
cause package is broken. 
1 2 1 4 
Table 10. Deviation/error situations in Sterilization 
 
5.3.9 Customer packing 
 
Issues encountered are incorrect labelling, wrong product in the box, heat sensitive 
indicator is missing and visual defects in the pouch. In OPF this happens very rarely, at 
most a few times in a year. One expert was uncovered by the survey. If products are 
subjected to higher temperatures then indicated, during transportation for example, 
their properties might change. Self-reinforced products loose orientation that can cause 
products to shrink in length and grow in width.   
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Label information 
and product inside 
the box do not 
match 
Product in the box or label 
attached on the box is incor-
rect due to human error. In 
worst case scenario product 
will reach end customer. 
1 3,66 3,33 8 
Temperature indi-
cator is missing 
Temperature indicator miss-
ing. Indicator has not been 
attached or has been re-
moved.  
1 3 3 7 
Pouch or pouch 
seal defective 
Defect is detected in the 
pouch. Pouches are visually 
checked before packing to 
hospital box.  
2 2 2 6 
Table 11. Deviation/error situations in Customer Packing 
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5.3.10 Release 
 
Encountered issues include lost documentation, documentation deviation, missing 
measurement results, non-sterile product has been released and release of products 
which are out of tolerance. Some of the issues happen monthly like missing measure-
ment results or document deviation, others happen very rarely. One expert was uncov-
ered by the survey. 
 
Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Release of unster-
ile products 
Product sterilization has not 
been verified. 
1 4 3 8 
Release of prod-
ucts out of toler-
ance 
Product properties have not 
been verified. 
1 3 2,5 6,5 
Documentation 
lost or insufficient 
Documentation like meas-
urement results are missing.  
Documents usually misplaced 
or accidentally thrown away.  
2 2 1,75 5,75 
Table 12. Deviation/error situations in Release 
 
5.3.11 Laboratory Measurements 
 
Laboratory issues include problems with IV-equipment, product set incorrectly into test-
ing jig, choosing of wrong method, analyzer computer crashes, Gas Chromatography 
(GC) equipment stops in the middle of the run, equipment not calibrated and incorrect 
products measured.  Issues besides crashing computer are quite rare.  
 
Misunderstandings of work instructions is one of the biggest risks and causes that pro-
cess has not been done according to instructions. Most common issue in materials is 
too high amount of additive in extruded material. Other encountered issues are that 
product after sterilization step does not pass required mechanical tests and sterilized 
batch has to be scrapped. In 2005 solvent supplier provided solvent that was in specifi-
cations, but yielded incorrect results. This was a wide issue in the area and it took a 
long time to find the root cause of the issue. Human errors can occur in weighing the 
samples for example. This is one of the many reasons why Laboratory always uses 
reference samples to verify the results.  
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Deviation/Issue Description Probability Severity Detection 
Risk 
factor 
Incorrect process 
used in laboratory 
measurements 
Raw material, subassembly or 
final product properties meas-
ured using incorrect process. 
Results are not reliable. 
1 3 3 7 
Wrong product 
measured 
During measurement material 
or product codes have been 
mixed and wrong product has 
been tested. Results are not 
reliable. 
1 3 3 7 
Measurement 
device is not cali-
brated 
Raw material, subassembly or 
final product properties meas-
ured using not calibrated 
equipment. Results are not 
reliable. 
1 3 2 6 
Product incorrect-
ly setup in the 
testing gauge 
Different products have sepa-
rate testing gauges and some-
times incorrect one is used. 
1 2 2 5 
Analyzer comput-
er/software crash-
es 
Computer or software mal-
function. Usually in the middle 
of the measuring run. No dan-
ger to end product, but results 
will be delayed.  
2,5 1 1 4,5 
Issues in IV-
measuring equip-
ment 
Equipment used to measure 
internal viscosity malfunctions. 
No risk for end product, but 
results will be delayed. 
2 1 1 4 
Incorrect method 
selected with MTS 
equipment 
MTS equipment software has 
different programmed meth-
ods for products. Results are 
not valid when using the 
wrong one. Issue is detected 
by reviewing results. 
1 1 2 4 
Instrument tool 
not properly at-
tached 
Torsion head instrument is not 
properly in place. Detected by 
reviewing results graph. 
1 1 1 3 
Table 13. Deviation/error situations in Laboratory measurements  
 
5.4 Solution toolkit for manufacturing process steps 
 
Solution toolkit is a set of short instruction on how to address manufacturing step is-
sues described above. More detailed instructions are available in documentation pro-
vided to receiving sites. In some cases CAPA (Corrective Actions and Preventive Ac-
tions) process has to be initiated in order to find the root cause of the issue and imple-
ment corrective actions according to quality assurance process. Instruction of the OPF 
CAPA process are provided to receiving sites and process is not explained in this pa-
per. Tools given here are a good starting point when an issue in manufacturing is en-
countered.  
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5.4.1 Compounding 
 
Solution for assembly issues is more on-the-job practice with mentors, who verify that 
machine is assembled correctly. On the shelf spare parts are available from Europe 
within two to three days delivery time. If something major like cylinder or screw breaks, 
the parts delivery time is months up to six months. 
Experienced maintenance person can adjust the equipment when scale equipment 
displacement increment is noticed. 
Close co-operation with the equipment and raw-material suppliers is very important and 
contacts should be created by face to face visits. K-fare in Germany is a good place to 
meet the suppliers. 
Trained persons should start immediate training for more operators in receiving loca-
tion to mitigate risk of knowledge centering only on few persons.. Compounding 
knowledge can also be purchased from U.S. in case the in-house compounding does 
not work. Operators should also have a basic theoretical training about compounding 
basics, which was not given at OPF. Consulting or expatriate contracts with OPF ex-
perts would mitigate risks 
 
 
Deviation/Issue Solution 
Feeder malfunction. Adding 
additive is not working. 
Feeder is disassembled and re-assembled. Alarm should 
installed in case the feeder stops. Operators have noticed that 
if sieve is left a bit loose, the issue is mitigated.  
Sensor malfunction Replace faulty sensor 
Raw Material issues and con-
tamination 
Raw material issues are solved with supplier and/or using 
external services determined by deviation- or CAPA process. 
Contamination issues follow the same procedure.  
Production run using validated 
parameters not possible 
Production run outside recommended parameters is solved 
internally using deviation- or CAPA process.  
Table 14. Solutions for Compounding 
 
Deviation/Issue Solution 
Contamination Equipment is cleaned and deviation process initiated. 
Pellet IV too high or low  Batch goes under deviation process and new measurements 
are taken from the batch in order to verify the results. If still 
invalid the Lot is scrapped and Deviation/CAPA process 
started. 
Equipment produces defect 
pellets, especially the lenght 
can vary. 
Equipment maintenance and adjustment. Especially sharp-
ening of the blades. 
Incorrect parameters Equipment parameters are adjusted through deviation pro-
cess.  
Table 15. Solutions for pelletizing 
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5.4.2 Self-Reinforcing 
 
Troubleshooting knowledge could be increased by more persons attending extensive 
training in OPF with proven capabilities to perform the step. Expert visits in receiving 
facility and consulting or expatriate contracts with OPF experts would also mitigate 
risks. Most issues are caused by inexperienced operator. 
 
 
Deviation/Issue Solution 
Billet shearing strength too low 
or other mechanical properties 
out of tolerance. 
Draw-ratio is to be increased and/or temperature parameters 
adjusted. In some cases corrective actions via Deviation- or 
CAPA process. 
Billet surface quality poor 
Parameters are adjusted and billet scrapped using deviation 
process. 
Reinforcement process cannot 
be run with validated parame-
ters 
Corrective actions via deviation- or CAPA process. 
Billet diameter out of tolerance 
Stop the self-reinforcement, Select more suitable drag-stone 
and adjust drawing parameters, often lower temperature and 
drawing speed. 
Table 16.  Solutions in Self-reinforcement 
 
5.4.3 Peeling, Cutting and Machining 
 
Change of tools and slight adjustments if displacement increment occurs. 
Two machine system used in OPF was found good especially minimizing scrap. Scrap 
is more expensive then machine time and special tools needed for ImplantX would oc-
cupy too many tool slots in one machine system. 
Solution for high quality tool purchasing is at least in the beginning to acquire tools from 
the OPF tool supplier in Finland until equally high quality supplier in US is identified. 
Using the same equipment in receiving site and sending site would mitigate risks, be-
cause machining programs and tools could be directly transferred. On-site-training 
would also be more beneficial, because trained persons could apply their new skill the 
same way as in sending site. No need for process changes and support from sending 
site would be easier to provide. 
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Deviation/Issue Solution 
Out of tolerance Adjust machining parameters or Initiate Deviation- and CAPA 
process. Improve work instructions. 
Missing measurements More detailed instructions and supervision. Measurements can 
be completed afterwards with required amount of measured 
samples.  
Fractures Initiate Deviation process 
Contamination Initiate deviation process and based on severity CAPA process. 
Root cause analysis with measurements in co-operation with 
external service providers and corrective actions implementa-
tion. 
Equipment malfunction  Initiate deviation process. Repair faulty/worn out parts and 
complete maintenance. 
Insert issue or insert hole 
offcentre 
Development and/or maintenance of insert tool. Insert parame-
ter optimization. 
Burr in products Adjust machining parameters 
Table 17. Solutions in Machining 
 
5.4.4 Finishing 
 
Solutions for the finishing process are listed in the table below. 
 
Deviation/Issue Solution 
Paraffin content too high 
Rewashing of the products. Maintenance of ultrasonic washing 
equipment, change of process and possible re-validation. 
Unfinished product goes to 
next manufacturing step 
Adding another inspector to check the products. 
Burrs in the product Return product to finishing for rework. 
Product cannot be cleaned Add more washing time or intensity. 
Product is not dry Adjust drying parameters and verify the result. 
Table 18. Solutions in Finishing 
 
5.4.5 Injection Moulding 
 
OPF does 100% quality assurance verification for the instrument hole with an instru-
ment gauge to detect issues with Instrument hole. Issue with scale feeder is solved by 
resetting error and restarting the machine. This does not cause scrap products or other 
issues. In case of power outage lasting longer than 10 minutes the defective material 
has to be removed and process restarted from the beginning. Mould breakage issues 
are solved by fixing the mould if possible or ordering a new mould from the supplier. 
Delivery time from Finland supplier is estimated 4-5 weeks. 
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Deviation/Issue Solution 
Instrument hole defect Adjust parameters and/or do surface treatment to the core print. 
Contamination 
Initiate deviation- or CAPA process. Conduct Root cause analy-
sis and implement corrections. 
Suction at the base of the 
product 
Adjust parameters 
Out of tolerance 
Adjust process parameters like altering switching point, raising 
or lowering temperature, adjusting speed and/or pressure. Ad-
just feeding length. If there is any changes to product measure-
ment or form Initiate deviation- or CAPA process, because 
mould has to be reworked. 
Physical properties out of 
tolerance 
Adjust parameters 
Product defect caused by 
mould damage 
Sent mould for repairs. If repair not possible the new mould has 
to be manufactured. Estimated delivery time 2-4 weeks. 
Table 19. Solutions in Injection moulding 
 
5.4.6 Packing 
 
Sealing equipment needs to be good and quality assurance tight that no defect prod-
ucts slip through. Extra care when packing bigger products. 
 
Deviation/Issue Solution 
Seal defective 
Every pouch is checked and defect pouches are scrapped. 
Product is re-sealed in new pouch. 
Pouch is not sealed 
Every Pouch is re-checked in customer packing step.  Seals are 
checked in two manufacturing steps: in Packing and customer 
packing. 
Contamination in the pouch 
Defect pouch is scrapped and replaced. If the defect is detected 
in the customer packing step, the product and pouch is 
scrapped. 
Incorrect product in the 
pouch 
Products, amounts and labels are verified in two steps. 
Table 20. Solutions in Packing 
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5.4.7 Gamma Packing 
 
Solutions for the Gamma Packing process are listed in the table below. 
 
Deviation/Issue Solution 
Products go to incorrect 
Gamma program 
Laboratory measurements after gamma treatment 
Gamma sterilization fails Gamma dose set to required levels 
Gamma dose varies Optimize packing size and shape. 
Table 21. Solutions in Gamma Packing 
 
5.4.8 Sterilization 
 
Solutions for the sterilization process are listed in the table below. Co-operation with 
the service provider and scheduled audits are key to successful operation. 
 
Deviation/Issue Solution 
Bioburden level too high. 
Too low Gamma dose 
Initiate deviation process. Issue verified by using external labor-
atory tests (Nelson, bacteria culture). 
Gamma dose too high 
Laboratory measurements verify that product properties have 
not changed beyond acceptable levels. 
Package is broken during 
procedure 
Initiate deviation- and/or CAPA process. Improve protective 
packaging. 
Table 22. Solutions in Sterilization 
 
5.4.9 Customer Packing 
 
Solutions for the customer packing process are listed in the table below. 
 
Deviation/Issue Solution 
Label information and prod-
uct inside the box do not 
match 
Improve customer packing procedures via CAPA process. 
Train/choose personnel who are skilled and thorough for this 
step. Issue can be detected in release step.  
Temperature indicator is 
missing 
Improve customer packing procedures via CAPA process. 
Train/choose personnel who are skilled and thorough for this 
step. Issue can be detected in release step.  
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Pouch or pouch seal defec-
tive 
Visual defects are generally quite obvious. The pouch and 
product will be scrapped. 
Table 23. Solutions in Customer Packing 
 
5.4.10 Release 
 
Solutions for the release process are listed in the table below 
 
Deviation/Issue Solution 
Release of unsterile products Initiate CAPA process 
Release of products out of 
tolerance 
Initiate CAPA process 
Documentation lost or insuf-
ficient 
Find the lost documentation. In some cases new measurements 
can be made. Initiate deviation- or CAPA process.  
Table 24. Solutions in Release 
 
5.4.11 Laboratory Measurements 
 
Human errors cause most issues and recommended solution is providing more training 
and making improvements to work instructions. 
 
Deviation/Issue Solution 
Incorrect process used in 
laboratory measurements 
Initiate CAPA process and additional training for Laboratory 
personnel 
Incorrect product measured Initiate CAPA-process and additional training for Laboratory 
personnel how to handle samples. 
Measurement device is not 
calibrated 
Initiate CAPA process 
Product incorrectly setup in 
the testing gauge 
Correct instrument gauge is applied and the tests rerun 
Analyzer computer/software 
crashes 
Restart the equipment and rerun the measurement. Contact IT 
department. If problem persists initiate deviation- or CAPA pro-
cess.  
Issues in IV-measuring 
equipment 
Equipment and measurement restart 
Incorrect method selected 
with MTS equipment 
Tests are rerun with correct method 
Instrument tool not properly 
attached 
Attach the instrument head properly and rerun the tests. 
Table 25. Solution in laboratory measurements 
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5.5 Summary of proposal 
 
Results suggest the importance of transfer planning before actual transfer operations 
begin. Thorough planning and clear responsibilities will help to identify and avoid is-
sues during transfer which affect the ability to reach transfer goals. Any changes to 
processes/equipment should be done in sending location before the transfer if possible, 
in order to mitigate risks. Identifying knowledge holders in the sending organization and 
using them as mentors in training of experienced recipient personnel is of key im-
portance for successful manufacturing knowledge transfer on the manufacturing floor. 
Cultural differences have an effect to the transfer and language in particular can be an 
obstacle at the beginning. A good communications plan would help mitigate cultural 
related risks. Once committed Finnish are professional and co-operative in the transfer 
project, and no significant cultural obstacles between Finnish and US personnel were 
encountered.  
In ImplantX product transfer to US, company had to decide between two different man-
ufacturing methods or transfer them both. Choosing Injection moulding method is rec-
ommended because it is simpler, rigorously validated and more cost efficient than the 
machined method. Initial results with injection moulding method has been positive and 
receiving organization has been able to produce quality products. Combination of thor-
oughly validated simpler manufacturing process, experienced injection moulding per-
sonnel at receiving site and commonly available machinery contribute to the success. 
Previous to Injection moulding manufacturing step are the more challenging com-
pounding and pelletizing steps. These manufacturing steps provide raw material to 
injection moulding step and are vital to the process. It is recommended to secure con-
sulting or expatriate contract with one of the process experts with extensive experience 
in biodegradable raw materials. 
Risk Analysis of the manufacturing steps revealed most commonly encountered issues 
in OPF and survey with the interviews provided recommended solutions. These will 
most likely assist in the continuous manufacturing of ImplantX biodegradable implant 
product in the receiving site. 
Research results suggest that the skills and processes acquired in transfer and manu-
facturing of ImplantX can be applied for other OPF biomaterial implant products, with 
the exception of self-reinforcement step of the machined process. 
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6 Feedback to proposal 
 
Proposal was sent to the company for review and Managing Director of the company 
gave feedback in the phone interview. In his opinion the results were very truthful and 
valid. All the persons interviewed were either manufacturing step experts or deeply 
involved with the transfer project.  Results can and probably will be used in the contin-
uous production of biomaterial implants and in future manufacturing transfer projects. 
Thesis usefulness as a general guide was questioned, since it has a lot of company 
related detailed information. No changes or additions to the proposal were requested 
beyond removing company identifying information. 
  
7 Conclusions 
 
International manufacturing transfer project has many variables, barriers and driving 
factors that affect the outcome of the transfer. Because of the variables every transfer 
project is more or less unique. Manufacturing transfer is similar to any other big interna-
tional project and good project management rules apply. It is recommended to have 
clear roles. There should be overall transfer project manager and local project manager 
in each site to improve communication and organization of the transfer project matters. 
Good planning before starting the transfer operations and identifications of transfer 
variables is important in order to achieve transfer goals. In this case knowledge transfer 
was especially important since some of the technologies and equipment transferred 
were proprietary. Properly documented and validated manufacturing processes and 
receiving sites previous experience working with biomaterials makes manufacturing 
transfer more feasible especially if processes are transferred without changes. All the 
process changes should be done at the sending site prior to the transfer. Cultural and 
language issues add extra challenges to the transfer, but no major issues were en-
countered between US and Finnish personnel. Success of the transfer project can be 
evaluated by comparing receiving site performance versus the sending site. 
Author has compiled a best practices process for the manufacturing transfer of the bi-
omaterial implant product, which may be used as reference for similar future transfers. 
Manufacturing process step risk analysis and solutions toolkit was created based on 
the survey and expert interviews. Reported results can be used in receiving site espe-
cially for transferred biomaterial product manufacturing step troubleshooting. Customer 
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was satisfied with the results and no changes or additions to the proposal were re-
quested beyond removing company identifying information. 
 
7.1 Next steps 
 
Recommended next steps are to actually utilize the best practices process in the com-
pany’s next similar transfer project and confirm that it can actually be used as an inter-
nal reference. Risk analysis can be used immediately to mitigate risks in relevant im-
plant manufacturing processes of the receiving sites. Solution toolkit can also be used 
to prepare for possible issues that will most likely be encountered in manufacturing of 
relevant biomaterial implant products. 
 
7.2 Evaluation 
 
The following paragraphs evaluate the results of the research and its validity. 
7.2.1 Outcome versus Objective 
 
The best practices process proposal was created. Manufacturing process step 
risks/issues and solutions were uncovered and reported. In this sense research objec-
tives were reached as planned. There are some manufacturing processes especially in 
Gamma packing and Sterilization were no expert interviews were conducted and au-
thor has little personal experience, so data in those particular processes is mostly 
based on the survey and knowledge gathered in prolonged engagement in the case 
company. Solutions for issues in these above mentioned steps are in some cases so 
varied that only solutions is to start Corrective Actions and Preventive Actions (CAPA) 
process in order to remedy the issue. Case company did not have template for manu-
facturing transfers when the transfer project was started. They can now use the best 
practices process described in this thesis as a high-level template for basis of the more 
detailed transfer project plan. 
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7.2.2 Reliability and Validity 
 
The validity of the qualitative research is a concern. 
 
There is a general consensus, however, that qualitative inquirers need to 
demonstrate that their studies are credible (John W. Creswell and Dana L. Miller 
2000). 
 
To address the issue of validity author uses lenses of the researcher, study participants 
and readers. Lenses refer to researcher bringing their study under different viewpoints 
in order for establishing validity (John W. Creswell and Dana L. Miller 2000). 
The author had worked in the case company for over five years before the transfer pro-
ject was started. After transfer project was initiated the author was responsible for IT 
related matters in the transfer project. Researcher was not directly responsible for 
manufacturing transfer steps, but had continuous access and discussions about them 
with persons responsible. So there was prolonged engagement in the field for almost 
two years, which was used to validate information received from the interviews and the 
survey. The end result of the transfer project was the closing of the OPF operations in 
Finland, which also meant that researchers’ position, along with the rest of the work-
force in OPF would also terminate after transfer is complete. This has possible implica-
tions in terms negativity or pessimism in the views of the interviewees or survey re-
spondents and emphasize some negative aspects of the transfer. 
Persons interviewed were either part of project management or experts with years or in 
some cases decades of experience. Compounding expert for example had extensive 
theoretical and practical knowledge of the process and Doctor of technology degree. 
He travelled and consulted at the receiving site multiple times and was very involved 
with compounding transfer project. Most of the process experts had similar case. Pro-
cess experts were uncovered via survey by asking participants to identify the go-to 
person in case they had an issue in manufacturing process step which they did not 
know answer to.  Interviewer answers were compared and for example in the question 
of the transfer order, most interviewees agreed that starting from end steps of the pro-
cess was the correct decision. Survey results were compiled and risk calculations were 
done in order to uncover highest potential risks and solutions. Project management 
which was actively involved in the transfer project had direct knowledge of what was 
going well and where there were issues. Based on their experience, experience of the 
process experts and relevant literature results were achieved. 
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Appendices 
 
 
Short summary of the interviews is described below.  
 
Summary of the interview with Finland Transfer Project Manager 19-June-2013. 
Interview first focused on the person’s role in the transfer process as a local transfer 
project manager and then about case product transfer. Case transfer has been relative-
ly successful when injection moulded method is concerned. Key points were that the 
process was quite new and recently developed at the sending site. Manufacturing pro-
cess was rigorously validated, which helped the transfer process. Next topic of discus-
sion was the transfer and operational organization at the sending and receiving sites. 
The resource differences and necessity of a backup resources was discussed and the 
need of a local transfer project manager in sending and receiving sites. After this there 
was discussion about training and knowledge transfer. Few people were sent from US 
for a training in multiple processes, which might be too demanding and concentration of 
only single process may have provide better results. Cultural differences were also 
discussed and differences between working culture and hierarchy was discussed. Finn-
ish operators have much broader responsibilities then US operators, which mainly push 
a button and run the machine. If the problem comes, the technical specialist will come 
and fix it. Problems are discussed openly in Finland, which is not the case in US, where 
there are generally more levels of hierarchy. No major issues with the language. Next 
the interviewee was asked how she would have done the transfer if she could decide. 
The regulatory issues should be addressed at early phase and maybe earlier on-site 
support in receiving site would be good. Engineering level support reception could be 
improved on US side. Next discussion was related to measuring the success of the 
transfer. No breaks on deliveries to customers and products that are according to spec-
ifications should be primary goals. Scrap levels also tell a lot about performance. Then 
there was discussion about risks and how to mitigate them, raw material is challenging 
especially making small products. Manufacturing should be transferred “as is” and any 
changes should be made in sending location. Processes should be kept as is and find 
a way to work with them in receiving site. 
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Summary of the interview with Finland Laboratory specialist 26-Sep-2013. 
Interview first focused on the person’s role in the transfer process as responsible for 
laboratory measurements transfer training and support, then about case product labor-
atory measurement transfer process. Visits from receiving site were conducted and 
then they purchased duplicate equipment for the receiving site. After receiving equip-
ment several visits to and from receiving site were conducted. Next topic of discussion 
was the laboratory measurement process. She explained all the measurements in de-
tail, filler content measurement and verification methods for example. Next the inter-
viewer was asked about error situations or other issues that have been encountered 
and possible solutions. Human error, according to her, is one of the most common rea-
sons why measurements fail. How language and cultural differences affect the labora-
tory transfer was discussed and no major issues reported in that sector. Risks after 
transfer were discussed and one solution suggested was the building of contacts with 
the people, that you might assist them even after transfer is completed. Risk is that 
only few persons in receiving site are familiar with the complete measurement process. 
All the product laboratory measurements are done using same process, so it can be 
applied to other implant products as well.  
 
 
Summary of the interview of the Managing Director 17-Sep-2013 
First topic was his role in the transfer process as a local Managing Director and then 
the transfer pre-planning matters were discussed. There was some room for improve-
ment in the pre-planning process. Estimated timetable was based on previous transfers 
was set to 18 months and receiving sites were set as two sites in US. Transfer activi-
ties were next. All Finland legal requirements in that were fulfilled and via bonus pro-
gram personnel was committed to the transfer project. Safety stocks were built in order 
to make sure customers will always have products available during transfer period. 
Transfer process order was discussed and importance of setting clear roles for transfer 
project members came up. Training plan could have been improved and transfer pro-
ject plan could have been better communicated. Sending expatriates to receiving sites 
would have mitigated risks according him. Local Transfer Project managers in the sites 
helped with a lot of practical issues, especially mitigating language and cultural issues. 
Usually when people spend time working in the same project, issues become common 
and that lowers barriers caused by cultural differences. 
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Finland subsidiary Interview with Production Team Leader 19.Sep-2013 an expert 
of finishing and packing process. 
First her role in the transfer project was discussed and then there were discussion 
about product finishing and packing process. Training process was discussed and it 
would be good if trainees from US have enough time to practice finishing and packing 
process. Common issues in finishing was discussed and in packing process especially 
with thicker products the product sealing into pouches can be a challenge. Pouches are 
rechecked when they return from sterilization to mitigate risks. Packing is similar with 
the other products, so skills acquired can be applied to other products. 
 
Finland subsidiary Interview with Production technician 26-June-2013 an expert 
of machining process 
His role in the transfer process as machinist specialist was the first topic and the prod-
uct machining process in detail was discussed next. ImplantX is manufactured using 
two different lathes with one operator. Special tools are used in machining. If the set-
tings are not correct, burr can form on the products, which makes measuring product 
difficult for example. Finishing step is also more time-consuming if there is lot of burrs. 
Machinist is the one controlling the whole process. Asking how the technician would 
himself do the transfer, he answered that he would transfer process as it is in Finland 
using the same machinery and 2-3 month on-site training time for machinists would be 
enough for basic manufacturing. Machining programs could be directly transferred and 
support from Finland and on-site training would be easier if the same machinery was 
used in receiving site. Troubleshooting and problem solving training would require 
more time than 2-3 months. Biggest risks after the transfer is complete according to the 
technician were related to difficulty of the raw material used (Billets). Billets should be 
manufactured at the same facility in order to provide fast interaction with billet creators 
and machinists, otherwise there is an extensive risk of scrap.  Process does not allow 
errors and tools used need to be of highest quality. Quality controls make sure that 
there is a very small change that any defect products reach customers.  
 
Finland subsidiary Interview with Production worker 27-June-2013 an expert of 
self-reinforcement process 
Her role in the transfer process was discussed first, she acted as trainer for US per-
sonnel. Self-reinforcement process was described next in detail and then common er-
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ror situations and solutions were processed, like incorrect temperature settings. Set-
tings has to be sometimes adjusted in the middle of the process and at times result is 
based on operators gut feeling (experience). Technician was asked how the knowledge 
has been transferred to US and she answered that by on-site trainings next to ma-
chine. Trainee has been taking notes and done actual hands-on practice. Cultural and 
language issues were effecting the training at the beginning, because common tech-
nical terms were lost and communication with foreign language was uncomfortable at 
first. When releasing that person understands and technical terms came more familiar, 
then training became easier. Future risks include having no problem solving support 
from sending site and getting a feeling of the process, which can only be acquired 
through experience. Risks could be mitigated by having experts from sending site to 
help ramp-up manufacturing and make sure process runs correctly. ImplantX billet self-
reinforcement process is slightly different from other products, so acquired skills cannot 
be directly applied to other self-reinforced products. 
 
Finland subsidiary Interview with Production technician 18-June-2013 an expert 
of injection moulding process 
Technician’s role in the transfer process was transfer of injection moulding (IM) pro-
cess, extrusion process and coordinating equipment transfer. Next injection moulding 
process was discussed. Product implantX had 35 different sizes, which meant 35 dif-
ferent moulds. IM knowledge transfer has been done by training two persons on the 
factory floor and then making visits to receiving site. Trainees also took notes, pictures 
and videos of the process. One of the trainees had previous experience in IM and this 
made transfer much easier, because he was familiar with the basics and only working 
with the difficult biodegradable raw material needed to be learned. This would take 
about two months compared to a person with no experience in IM would take a year to 
learn the process. Next the issues and solutions were discussed and one of the issues 
encountered is the power outage. If it lasts more than 10 minutes the raw material in 
the injection machine cylinder becomes defect and process has to be started from the 
beginning. In case of mould breakage, mould has to be repaired or new mould ordered 
from approved supplier. Discussing about risk mitigation, he said that expatriate expert 
from Finland to receiving site for 6 months would mitigate possible risks encountered. 
Training more expert in receiving site should be started at once. He also said that scrap 
rate is a good measurement of the transfer success. Skills acquired in manufacturing 
ImplantX are transferable to other similar products as well. 
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Interview with Finland subsidiary Interview with Research Development Manager 
19-Jun-2013 expert of extrusion process 
His role was transferring functions related to compounding process. He has over 20 
years of experience in compounding and biodegradable raw materials. ImplantX com-
pounding process was discussed in great detail. Extrusion billets are made with twin-
screw extruder by mixing polylactide and bioceramic components. End result of the 
process is a billet. It would be good for the trainees to learn theoretical and practical 
side of the process on-site before transfer. Knowledge of material, process and equip-
ment is required. There was extensive discussion about possible issues and it is possi-
ble to assemble the machine incorrectly and, in worst case scenario, cause machine 
breakage. This can cause even six month gap in production, because some parts are 
custom made and have long delivery times. Process transfer success can be meas-
ured by laboratory measurements of product properties (IV, internal viscosity) and oth-
er specifications. Troubleshooting and problem solving after support from Finland op-
erations are shut down is one of the risks, which can be mitigated by sending expert 
expatriates. Material and machine manufacturers cannot really help with technical 
compounding related issues. Compounding is the first process, so if it does not work 
properly the following process steps suffer, therefore this process step should be first to 
be transferred and planned properly, according to him. He confirmed that acquired 
compounding skills are transferrable to other similar products. 
 
Finland subsidiary Interview with Senior Project manager of ImplantX 11-Jun-
2013 
Discussions began about the implantX product, what purpose it is used for and manu-
facturing methods. Next was a discussion about the communication between sending 
and receiving site now and before the transfer. Exchange with the one of the receiving 
sites had been active and good, with emails and video conferences.  Knowledge trans-
fer of engineering knowledge in addition to process knowledge is important, so that the 
more complete picture of the product and its properties is understood. Success of the 
transfer can be measured with manufacturing, scrap% and amount of customer com-
plaints. Risks were discussed and because there are no replacement moulds, the 
mould breakage could cause 4-5 week delay in manufacturing. Material related risks 
can be mitigated by sending material experts as expatriates. There is still a risk that a 
lot of tacit knowledge is lost. There are probably a lot of steps in manufacturing that are 
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not documented in detail and are known to current operators, which have done dec-
ades of this work. The discussions continued on the ways to transfer this tacit 
knowledge to receiving site.   
 
US Based Company RSite2 Interview with Process Engineer 21-Aug-2013 
His role was as a supporting engineer and trainee in learning all manufacturing steps of 
ImplantX. Responsibility was to bring knowledge of the processes to receiving site and 
to start manufacturing there. Next there was discussion about manufacturing process 
training and methods. Hand-on training in combination with some training in theory with 
the people who know best is the best way according to him. The most difficult to learn 
is the processing of the raw material. Looking at pressures, temperature and clarity of 
billets is going to take experience. Cultural factors were discussed and he had previous 
experience from European culture, so for him difference was not that big, but some 
other people did not like European style of living. Daylight was different compared to 
US during summer months. Language was a hurdle at the beginning, but Finnish oper-
ators became much stronger when time past and felt more comfortable talking to US 
personnel. Office staff speaks pretty good English, so it was not a big hurdle. Next topic 
of discussion was how he would have done the transfer if he could decide and maybe 
more time for learning the raw materials is needed and transfer processes should be 
transferred “as is”. Everybody should know there role and support other departments. 
He felt that no expats were needed and couple of week’s trips for troubleshooting 
would be enough. 
 
US subsidiary RSite1 Interview with Overall Transfer Project Manager 21-Aug-
2013 
Her role as a coordinator between all three facilities was discussed first. Then the topic 
of pre-transfer planning was discussed and how that progressed, identifying products, 
markets and manufacturing methods. Finding a suitable manufacturing facility of the 
two available, planning the amount of safety stocks that needed to cover transfer peri-
od and regulatory impact. There was also a lot of other matters that needed to be taken 
into account. Then discussion progressed into actual transfer activities, which included 
building cleanroom facilities in receiving sites, purchasing or transferring equipment, 
translating documentations, training personnel and other actions needed. Some pro-
cess changes were done in sending site before transfer and that was a good idea ac-
cording to her. Cultural and language differences were discussed and she thinks that 
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Finnish people have been very professional through the whole transfer and very help-
ful. There has been some miscommunication due to language issues according to her, 
but no major issues were encountered. Next discussion was about the things she 
would have done differently and one was that maybe she would have sent more people 
to train and a bit earlier. Risks were discussed next and understanding how this type of 
raw material responds to the manufacturing processes was the biggest concern. Risks 
can be mitigated by having engineers and operators spend time in sending location 
and possible try maintain contacts, that they might even be able to call them after-
wards. After this discussion the measuring the success of the transfer was discussed 
and getting manufacturing up and running in the receiving sites without backorders or 
any kind of interruptions for delivery to customers would signal success. Then in the 
long run change in the complaint rate of products made in US compared to ones in 
Finland could be measured. 
 
Finland subsidiary Discussions with R&D Manager 9/2012 
These discussion were related to the company structure and products in general. 
There were multiple unrecorded discussion during September. 
 
US Based Company Discussions with US Vice President of Operations 9/2012 
There were multiple unrecorded discussions about company strategy, customer deliv-
ery goals and manufacturing best practices. Manufacturing process steps should be 
transferred “as is” for example. 
 
 
